好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2015 Annual Meeting | Poster Session 07

Thursday 04/23/15
02:00 PM - 06:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), Movement Disorders, Multiple Sclerosis, Neuro Trauma, Critical Care, and Sports Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-rehabilitation, Practice, Policy, and Ethics, Sleep
No CME available
Event Timeline
02:00 PM - 06:30 PM Abstract 001 - Indomethacin increases the latency to seizure onset and decreased the number of seizures in zebrafish seizure model
Patricia G. Barbalho, PhD
02:00 PM - 06:30 PM Abstract 002 - Iatrogenic Radiation Exposure from Neuroimaging May Increase the Risk of Cancer and Mortality in Patients with Epilepsy
Travis E. Losey, MD
02:00 PM - 06:30 PM Abstract 003 - Gray Matter Volume is Reduced in Focal Compared to Idiopathic Generalized Epilepsy
Monica B. Dhakar, MBBS
02:00 PM - 06:30 PM Abstract 004 - Predictors of In-Hospital Mortality in Status Epilepticus; Data from The Nationwide Inpatient Sample Database, 2008-2012
Nassim Naderi, MD
02:00 PM - 06:30 PM Abstract 006 - The Sabril® Registry After 5 Years: Patient Characteristics and Vision Loss
Robert C. Sergott, MD
02:00 PM - 06:30 PM Abstract 007 - Responder Rates by Study Phase in Conversion to Lacosamide Monotherapy Study: a Post-hoc Analysis
John M. Stern, MD, FAAN
02:00 PM - 06:30 PM Abstract 008 - Adjunctive Perampanel in Adolescents With Inadequately Controlled Partial Seizures: Efficacy and Safety Results From Study 235 (Phase II)
J Renfroe, MD
02:00 PM - 06:30 PM Abstract 009 - Assessing the Role of Cultural Perceptions and Knowledge of Epilepsy on Medication Adherence in a Multi-Ethnic Epilepsy Clinic: A Pilot Study
02:00 PM - 06:30 PM Abstract 010 - Reasons for Treatment Discontinuation and Switch in Patients with Epilepsy: A Retrospective Observational Study in a US Population
Maria Malmenäs, MSc
02:00 PM - 06:30 PM Abstract 011 - Cancer Risk is Not Increased in People with Relapsing Multiple Sclerosis Taking Cladribine
Julia Pakpoor, MBBS
02:00 PM - 06:30 PM Abstract 012 - Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11)
Gilles Edan, MD
02:00 PM - 06:30 PM Abstract 013 - Thalamic volume is associated with white matter integrity measures in multiple sclerosis
Mikolaj Pawlak, MD PhD
02:00 PM - 06:30 PM Abstract 014 - Increased coinfection of Human Herpesviruses 6A (HHV-6A) and HHV-6B in Multiple Sclerosis patients
Emily Leibovitch
02:00 PM - 06:30 PM Abstract 015 - An 8 Year Old Girl with Chronic Inflammatory Optic Neuritis (CRION): the Youngest Reported Case to Date
Ian T. Rossman, MD, PhD
02:00 PM - 06:30 PM Abstract 016 - The Clinical Course of Hair Thinning Associated with Teriflunomide: Case Series of Patients Who Participated in a Hair Photography Project
02:00 PM - 06:30 PM Abstract 017 - Baseline Demographics and Disease Characteristics from ORATORIO, a Phase III Trial Evaluating Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
Xavier Montalban, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 018 - Immune-cell NT-3 and beta-NGF are linked to regional brain volume in multiple sclerosis
Alicja Kalinowska-Lyszczarz, MD
02:00 PM - 06:30 PM Abstract 019 - Time Off From Work: a Matched Comparison of Fingolimod and BRACE in Patients with Multiple Sclerosis from the PANGAEA and PEARL Studies
02:00 PM - 06:30 PM Abstract 020 - Evaluation of Correlations between Cerebral MRI Volumes, Retinal Thickness, Cognitive Involvement and Clinical Features in Parenchymal Neuro-Behçet Patients
Tuncay Gunduz, MD
02:00 PM - 06:30 PM Abstract 023 - Sleep Disturbances in Persons With Epilepsy in Nigeria
Taofiki A. Sunmonu, MD, FAAN
02:00 PM - 06:30 PM Abstract 024 - Meta-analysis of risk factors for early and late seizures after acute stroke
Steven Tobochnik, MD
02:00 PM - 06:30 PM Abstract 026 - Headaches and Psychosomatic Complaints in Seizure Disorders
Brannon L. Vines, MD
02:00 PM - 06:30 PM Abstract 027 - Post-transplant Acute Symptomatic Seizures. Long Term Recurrence and Development of Epilepsy.
Maria E. Gonzalez Toledo, MD
02:00 PM - 06:30 PM Abstract 028 - Orgasmic Auras as an Initial Symptom of a Primary Brain Tumor: A Case Report and Literature Review
Robert L. Glover, MD
02:00 PM - 06:30 PM Abstract 029 - SeizED: Seizures in the Emergency Department
Angela Y. Peters, MD
02:00 PM - 06:30 PM Abstract 030 - Development of a claims-based classifier to identify Lennox-Gastaut Syndrome
Jesus E. Pina-Garza, MD
02:00 PM - 06:30 PM Abstract 031 - User Retention and Utilization of an Online Digital Health Platform for Epilepsy
John D. Hixson, MD
02:00 PM - 06:30 PM Abstract 032 - Effects of 好色先生 on Nurses' Assessments on an Epilepsy Monitoring Unit
Mona Stecker
02:00 PM - 06:30 PM Abstract 033 - Pregnancy Outcome in patients with epilepsy-Corniche Experience
02:00 PM - 06:30 PM Abstract 034 - Title: Down syndrome (DS) and epilepsy in adult patients
Martin Kriebaum
02:00 PM - 06:30 PM Abstract 035 - The Factors that Trigger Seizures in Elderly Patients
Serkay Demir
02:00 PM - 06:30 PM Abstract 036 - Childhood Trauma Is Associated With Stress Precipitated Epileptic Seizures in Adults
Ikjae Lee, MD
02:00 PM - 06:30 PM Abstract 038 - A case report of exacerbation of myoclonus in idiopathic generalized epilepsy from use of lacosamide
Arun Swaminathan, MD
02:00 PM - 06:30 PM Abstract 039 - Primary Lateral Sclerosis Plus Corticobasal Syndrome: a case series
Kimberly D. Johnson, MD
02:00 PM - 06:30 PM Abstract 040 - Enterovirus-D68 Associated Acute Anterior Horn Cell Injury
Jason Williams, MD
02:00 PM - 06:30 PM Abstract 041 - Differentiating Depression from PBA-Related Crying in ALS: Use of PHQ-9 and CNS-LS
Nimish Thakore, MD
02:00 PM - 06:30 PM Abstract 042 - Electrical impedance myography and quantitative ultrasound as biomarkers of disease progression in Duchenne muscular dystrophy: a preliminary analysis
Seward B. Rutkove, MD, FAAN
02:00 PM - 06:30 PM Abstract 043 - Pharmacokinetic Properties of Chronic Administration of Eteplirsen in the Treatment of Boys with Duchenne Muscular Dystrophy (DMD)
02:00 PM - 06:30 PM Abstract 044 - Evaluation of Th17 cell infiltration in thymectomy materials of acetycholine receptor antibody-positive myasthenia gravis patients
02:00 PM - 06:30 PM Abstract 045 - Myasthenia Gravis: Thymectomy And Quality Of Life
Yury N. Bykov, MD, FAAN
02:00 PM - 06:30 PM Abstract 046 - A Randomized Study of Exercise in Spinal and Bulbar Muscular Atrophy
Christopher Grunseich, MD
02:00 PM - 06:30 PM Abstract 049 - Hypoglossal Nerve Palsy is Associated with a Variety of Etiologies and Sometimes Results in Tongue Myokymia
Amro Stino, MD
02:00 PM - 06:30 PM Abstract 050 - Spectrum of Valosin Containing Protein (VCP)-opathy: A Case Series
Mohamed Kazamel, MD
02:00 PM - 06:30 PM Abstract 051 - Clinical Utility of Voltage Gated Calcium Channel Antibody Titers
Karin Mente, MD
02:00 PM - 06:30 PM Abstract 052 - A study on natural history of Duchenne muscular dystrophy- Indian perspective
02:00 PM - 06:30 PM Abstract 053 - Stiff Person Syndrome: A case series
Duaa Jabari, MD
02:00 PM - 06:30 PM Abstract 054 - Non-Neuromuscular Manifestations of Spinal and Bulbar Muscular Atrophy
02:00 PM - 06:30 PM Abstract 055 - The wide clinical phenotype of Kennedy’s disease.
Giorgia Querin, MD
02:00 PM - 06:30 PM Abstract 056 - Generalized Myasthenia Gravis in Argentina: Serological Profile and Clinical Characteristics. A Hospital-based Study.
Florencia Aguirre
02:00 PM - 06:30 PM Abstract 057 - Prevalence of Cardiac Arrhythmia in Myasthenia Gravis
Rachana Gandhi, MD
02:00 PM - 06:30 PM Abstract 058 - Ptosis in a Cohort of patient with Late Onset Pompe Disease (LOPD) from Argentina.
Claudio G. Mazia, MD
02:00 PM - 06:30 PM Abstract 059 - Magnetic Resonance Imaging Assessments of two doses of Drisapersen in the Treatment of Ambulant Boys with Duchenne Muscular Dystrophy
02:00 PM - 06:30 PM Abstract 061 - ManNAc Is Safe and Increases Sialic Acid Production in GNE Myopathy
Bradley Class
02:00 PM - 06:30 PM Abstract 063 - "Toe Off" Style Carbon Fiber Ankle Foot Orthoses in Neuromuscular Disease: The OSUMC Experience
Wendy M. King, PT
02:00 PM - 06:30 PM Abstract 064 - Comparison of length of hospital stay between treatment with plasma exchange versus IVIg in mild Guillain-Barré Syndrome.
Vladimir Klinov, MD
02:00 PM - 06:30 PM Abstract 065 - Acthar in Dermatomyositis and Polymyositis Treatment Registry: An Interim Analysis
Todd D. Levine, MD
02:00 PM - 06:30 PM Abstract 066 - Predicting Responsiveness to Study Drug Before Randomization in the DAPPER Trial of 3,4-Diaminopyridine (3,4-DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)
Donald B. Sanders, MD, FAAN
02:00 PM - 06:30 PM Abstract 067 - A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS)
James D. Berry, MD MPH
02:00 PM - 06:30 PM Abstract 068 - First Human Use of High Dose IV Trehalose: Safety, Tolerability and Pharmacokinetic Results from the Oculopharyngeal Muscular Dystrophy (OPMD) Therapy Trial
Zohar Argov, MD
02:00 PM - 06:30 PM Abstract 069 - Low Dose Prednisone in Seropositive Myasthenia Gravis
Ahmad R. Abuzinadah, MBBS
02:00 PM - 06:30 PM Abstract 070 - Myasthenia Gravis Exacerbation after Discontinuing Mycophenolate: A Case-Control Study.
Bjorn E. Oskarsson, MD, FAAN
02:00 PM - 06:30 PM Abstract 071 - Prompt Diagnosis of GBS is Improved by Emergency Department Neurological Consultation and Associated with Better Outcomes.
Divyanshu Dubey, MD, FAAN
02:00 PM - 06:30 PM Abstract 072 - YouTube and Peripheral Neuropathy: What Patients Want?
02:00 PM - 06:30 PM Abstract 074 - Novel OPA1 Mutation in Syndromic Mitochondrial Dominant Optic Atrophy (DOA+): A Case Report
Varoon R. Thavapalan, MD
02:00 PM - 06:30 PM Abstract 075 - Six-Minute Walk Test Is Reliable and Valid in Spinal Muscular Atrophy
Sally Dunaway, DPT
02:00 PM - 06:30 PM Abstract 076 - The Utility of Paraneoplastic Antibody Testing in the Diagnosis of Motor Neuron Disease
Najwa Al-Bustani, MD
02:00 PM - 06:30 PM Abstract 077 - Antilipemic Agents And Creatine Phosphokinase: Epidemiologic Study And Clinical Anatomical Analyses Of 55 Patients
Alzira A. Carvalho, MD
02:00 PM - 06:30 PM Abstract 078 - Ocular LEMS or MG and LEMS Overlap Syndrome?
Watcharasarn Rattananan, MD
02:00 PM - 06:30 PM Abstract 079 - Determining the yield of electrodiagnostic (EDX) studies in patients referred for neck and/ or upper extremity pain
Rajesh K. Gupta, MBBS
02:00 PM - 06:30 PM Abstract 080 - Clinical Features of HNPP Patients With the 17p11.2 Deletion
Aline P. Oliveira
02:00 PM - 06:30 PM Abstract 081 - Prevalence and Characteristic Features of Anti-Human Neurofascin 155 Antibody-Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Hidenori Ogata
02:00 PM - 06:30 PM Abstract 082 - Neuropathy symptoms are associated with increased fall risk in patients receiving potentially neurotoxic chemotherapy
Noah A. Kolb, MD
02:00 PM - 06:30 PM Abstract 083 - Elevated sNCAM-1 concentrations in sera from patients with polyneuropathies
Adam Andrzey Niezgoda
02:00 PM - 06:30 PM Abstract 084 - Clinical Manifestations of Isolated Elevated Homosysteine-induced Peripheral Neuropathy in Adults
Varun Shandal, MD
02:00 PM - 06:30 PM Abstract 085 - The Clinical Features of Neuropathies Associated with Monoclonal Gammopathies
Aline Herlopian, MD
02:00 PM - 06:30 PM Abstract 086 - A Case Report and Management of Familial Amyloid Polyneuropathy Transmitted By Domino Liver Transplantation With Disease Onset at Less Than 3 Years
Sharmi T. Shafi, MD
02:00 PM - 06:30 PM Abstract 087 - Elevated plasma level of homosysteine and peripheral neuropathy in adults
Jin J. Luo, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 088 - Chronic Severe Polyradiculoneuropathy with Ophthalmoplegia and Encephalopathy Due to Thiamine Deficiency in a Bariatric Surgery Patient
Carolyn Mehaffey, MD
02:00 PM - 06:30 PM Abstract 090 - Incidence and Risk Factors for Neuropathy Following Primary Total Knee Arthroplasty
Joseph Nguyen, DO
02:00 PM - 06:30 PM Abstract 091 - The Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome
Hannah Homafar, MD
02:00 PM - 06:30 PM Abstract 092 - Incidence and Risk Factors for Neuropathy Following Primary Total Hip Arthroplasty
Joseph Nguyen, DO
02:00 PM - 06:30 PM Abstract 093 - Clinical Characteristics and Treatment Response of Patients with Chronic Inflammatory Demyelinating Neuropathy Refractory to Standard Therapy.
Artem Kaplan, MD, PhD
02:00 PM - 06:30 PM Abstract 094 - Subcutaneous Immunoglobulin (IgPRO20) for Maintenance Treatment in Patients with Multifocal Motor Neuropathy
Hans D. Katzberg, MD, FAAN
02:00 PM - 06:30 PM Abstract 095 - A novel evidence based phone system reduces symptoms of chemotherapy induced neuropathy
Noah A. Kolb, MD
02:00 PM - 06:30 PM Abstract 096 - Small Fiber Neuropathy: Gender Differences in Skin Biopsy and Clinical Findings
Joshua J. Weaver, MD, FAAN
02:00 PM - 06:30 PM Abstract 097 - Effect Of FTY720 (Fingolimod) In A New Preclinical Rat Model For Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
02:00 PM - 06:30 PM Abstract 098 - Biopsy and EMG Findings in a Case of Late-Onset Dropped Head Syndrome After Mantle Field Radiotherapy
Amro Stino, MD
02:00 PM - 06:30 PM Abstract 099 - The Rarity of Tarsal Tunnel Syndrome: Analysis of Cases Referred to an EMG Laboratory
Brion D. Reichler, MD
02:00 PM - 06:30 PM Abstract 100 - A Randomized, Double-Blind, Placebo-Controlled, 24-Week, Phase 2b Outcomes Study of 3 Different Doses of Encenicline or Placebo in Subjects With Mild to Moderate Probable Alzheimer’s Disease
Hans J. Moebius, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 101 - Efficacy and Tolerability of Memantine Extended Release Added to Stable Donepezil Regimen in Individuals with Moderate to Severe Alzheimer’s Disease: Subset Analysis of a Randomized Clinical Trial
George Grossberg, MD
02:00 PM - 06:30 PM Abstract 102 - Use of Quantile Regression to Characterize Solanezumab Effects across Percentiles of Disease Progression in EXPEDITION Alzheimer's Disease Trials
Yun-Fei Chen, PhD
02:00 PM - 06:30 PM Abstract 103 - Effects of Testosterone Supplementation and Serum Levels on Cortical Volume in Healthy Older Men
Jeremy Hua
02:00 PM - 06:30 PM Abstract 104 - Caregiver treatment preference/satisfaction and efficacy among patients in the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer’s disease (OPTIMA) study
Steven Ferris
02:00 PM - 06:30 PM Abstract 105 - Effects of a distinct phenolic complex on working memory performance in healthy men and women with age-associated memory impairment
Brenda Fonseca
02:00 PM - 06:30 PM Abstract 106 - Adding Memantine to Stable Cholinesterase Inhibitor Therapy in Patients with Moderate to Severe Alzheimer’s Disease is Associated with Improvement in Various Neuropsychiatric Symptoms: A Pooled Analysis
Gustavo Alva, MD
02:00 PM - 06:30 PM Abstract 107 - A Phase II Study to Evaluate the Efficacy and Safety of Plasma Replacement with 5% Albumin in Beta-amyloid Peptide Clearance in Cerebrospinal Fluid and Plasma, and its Clinical Effects in Patients with Mild-Moderate Alzheimer's Disease
Mercè Boada Rovira, MD, PhD
02:00 PM - 06:30 PM Abstract 108 - Delayed-Start Analyses of Solanezumab Phase 3 Studies in Mild Alzheimer’s Disease
02:00 PM - 06:30 PM Abstract 109 - PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer’s Disease/Dementia Cohort
Rachelle S. Doody, MD, PhD
02:00 PM - 06:30 PM Abstract 110 - Cognitive Dysfunction in Obese Individuals With or Without Metabolic Risk Factors
Alaa Abu Saleh
02:00 PM - 06:30 PM Abstract 111 - Refined sugar intake is associated with lower cognitive performance across the cognitive continuum but is not associated with preclinical cognitive decline in intact elderly subjects
Dasha Kenlan
02:00 PM - 06:30 PM Abstract 112 - Cardiovascular comorbidities and medication in dementia disorders
Pavla Cermakova
02:00 PM - 06:30 PM Abstract 113 - Involvement of Microbleeds, Representative of Cerebral Amyloid Angiopathy, in Cognitive Dysfunction in Alzheimer’s Disease and Parkinson’s Disease: An MRI Study
02:00 PM - 06:30 PM Abstract 114 - Endothelium-mediated changes in vascular tone and cognitive function in patients with subjective cognitive impairment: a pilot study
Gereon Nelles, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 115 - The Association between Pulse Pressure and Memory Functioning over time Depends on Baseline Systolic Blood Pressure
Eric M. McDade, DO
02:00 PM - 06:30 PM Abstract 117 - Regular aspirin use does not reduce risk of incident cognitive decline
Brendan J. Kelley, MD, FAAN
02:00 PM - 06:30 PM Abstract 118 - Early Diagnosis of Vascular Cognitive Impairment is Associated with Improved Adherence with Medical Treatment of Vascular Risk Factors
Angelia Kirkpatrick
02:00 PM - 06:30 PM Abstract 119 - Heart-Heath Intervention reduces cognitive decline in mild cognitive impairment of the cerebrovascular type: a randomized, placebo-controlled clinical trial
Gregory A. Jicha, MD, PhD
02:00 PM - 06:30 PM Abstract 121 - Detection of Paroxysmal Atrial Fibrillation in Very Young Cryptogenic Ischemic Stroke Patients under 40 Years: A Three Week ECG-Holter Monitoring Study
Michal Kral
02:00 PM - 06:30 PM Abstract 122 - Misdiagnosis in Young Patients with Ischemic Stroke
Emily Brereton
02:00 PM - 06:30 PM Abstract 123 - "Spicy Strokes": Synthetic Cannabis and Strokes in Young
Ahmad El Kouzi, MD, FAAN
02:00 PM - 06:30 PM Abstract 124 - Stroke in the Young: Etiologies and Risk Factors
Pandompatam Govind
02:00 PM - 06:30 PM Abstract 125 - Impact of stroke misdiagnosis on short-term and discharge use of vascular medications in young adults
Seemant Chaturvedi, MD, FAHA, FAAN
02:00 PM - 06:30 PM Abstract 126 - Body Mass Index and Stroke Subtype in a Young Adult Stroke Population
Jina M. Youn, MD, MS
02:00 PM - 06:30 PM Abstract 127 - Incidence of ischemic or hemorrhagic non-fatal strokes in hemophiliac adults and teenage children
02:00 PM - 06:30 PM Abstract 128 - Primary Angiitis of the Central Nervous System (PACNS) presenting with intracerebral hemorrhage (ICH): three cases associated with chronic use of over-the-counter vasoconstrictive drugs
Ruchira M. Jha, MD
02:00 PM - 06:30 PM Abstract 129 - Post-stroke depression (PSD) in sub-Saharan Africans- validation of the Japanese stroke scale for depression. (JSS-D).
Frank A. Imarhiagbe, MD
02:00 PM - 06:30 PM Abstract 130 - Interactive Voice Response_A Novel Approach to Post-Stroke Depression Monitoring
Lesli E. Skolarus, MD, MS
02:00 PM - 06:30 PM Abstract 132 - Selective Serotonin Reuptake Inhibitors for Prevention of Post Stroke Depression: A Meta-Analysis
Dan Neftalie A. Juangco, MD
02:00 PM - 06:30 PM Abstract 133 - Cognition and major depression after frontal and cerebellar stroke
Mario F. Dulay, PhD
02:00 PM - 06:30 PM Abstract 134 - Anxiety influences TIA diagnosis
William Sugrue, MD
02:00 PM - 06:30 PM Abstract 135 - Competitiveness in passive NBA spectating and Cerebrovascular Accident Frequency
Danielle L. Weiss, MD
02:00 PM - 06:30 PM Abstract 136 - Basal ganglia stroke and apathy: a clinico-radiological study
Emmanuel THOMAS
02:00 PM - 06:30 PM Abstract 137 - The quantitative analysis of temporal lobes and Hippocampi in patients diagnosed with transient global amnesia (TGA).
Raja S. Boddepalli, MD
02:00 PM - 06:30 PM Abstract 138 - Intravenous Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke in the REGARDS Study
Kara A. Sands, MD
02:00 PM - 06:30 PM Abstract 139 - Quality Assessment of Vascular Disease Prevention Practices in High Risk Urban Women
Seemant Chaturvedi, MD, FAHA, FAAN
02:00 PM - 06:30 PM Abstract 140 - Racial Variation in Association of Elevated Factor VIII and Stroke Outcome
Lauren Dowell
02:00 PM - 06:30 PM Abstract 141 - Racial differences in the Risk factors, Severity, Outcomes and Treatment in Acute Ischemic Stroke
Muhammad Ahmed N. Chauhan, MD
02:00 PM - 06:30 PM Abstract 143 - Comparison of major modifiable stroke risk factors associated with lacunar strokes in anterior and posterior circulation in multiethnic cohort
Sebina Bulic, MD
02:00 PM - 06:30 PM Abstract 144 - An Association between Diabetes and Late Hospital Arrival among low-income Hispanic Stroke Patients
02:00 PM - 06:30 PM Abstract 145 - Narrative Communication using a Gospel Musical and Telenovela may improve EMS activation for stroke among Blacks and Hispanics
Olajide A. Williams, MD
02:00 PM - 06:30 PM Abstract 146 - Are there Different Rates of Acute Stroke Risk Factors in the South Texas Mexican American population?
Wondwossen G. Tekle, MD
02:00 PM - 06:30 PM Abstract 149 - Earlier Cooling in Post Cardiac Arrest Patients Fails to Show Benefit
Preet M. Varade, MD
02:00 PM - 06:30 PM Abstract 150 - Management of Refractory ICP in a Case of Fulminant Acute Disseminated Encephalomyelitis
Nicole D. Mahdi, MD
02:00 PM - 06:30 PM Abstract 151 - DTI changes in bilateral uncinate fasiculus following acute, but not chronic symptomatic concussion in adolescence.
Rejean M. Guerriero, MD
02:00 PM - 06:30 PM Abstract 152 - Clinical Correlates of Diffusion Tensor Imaging in Repetitive Head Trauma
Charles Bernick, MD
02:00 PM - 06:30 PM Abstract 153 - Do Football Helmet Add-Ons Reduce Concussion Risk?
John D. Lloyd, PhD
02:00 PM - 06:30 PM Abstract 154 - Comparable levels of phosphorylated tau in epileptic brain and chronic traumatic encephalopathy
02:00 PM - 06:30 PM Abstract 155 - Younger children recover faster and have less premorbid conditions than adolescents with concussion
Rejean M. Guerriero, MD
02:00 PM - 06:30 PM Abstract 156 - Volumetric Measurements of Cytotoxic and Vasogenic Edema Following Traumatic Brain Injury Using Magnetic Resonance Imaging
Brian Stephens, MD
02:00 PM - 06:30 PM Abstract 158 - Sensitivity and Specificity of Altered Propulsive Force Following Concussion
Jessie Oldham
02:00 PM - 06:30 PM Abstract 159 - Initial Concussion Presentation Does Not Predict Acute Impairments in Transitional Dynamic Postural Control
Jessie Oldham
02:00 PM - 06:30 PM Abstract 160 - The Impact of Games Played on Age Related Changes in White Matter Mean Diffusivity among Retired NFL Athletes
Kyle B. Womack, MD
02:00 PM - 06:30 PM Abstract 161 - Postural Stability in Veterans with Mild Traumatic Brain Injury and Disequilibrium
Mark F. Walker, MD
02:00 PM - 06:30 PM Abstract 162 - 7 Tesla Brain MRI Characteristics Among Concussion Patients
Andrew Russman, DO, FAAN
02:00 PM - 06:30 PM Abstract 163 - Physicians' Management Practices and Perceived Health Risks when Postconcussion Symptoms Persist
Sean C. Rose, MD, FAAN
02:00 PM - 06:30 PM Abstract 164 - Von Willberand Factor And Cellular Fibronectin Plasma Concentrations Are Increased In Mild Traumatic Brain Injury (TBI) With MRI Evidence Of Microvascular Injury.
Tanya Bogoslovsky, MD, FAAN
02:00 PM - 06:30 PM Abstract 165 - A Systematic Video Analysis of Concussion in the National Rugby League
Andrew Gardner
02:00 PM - 06:30 PM Abstract 166 - Evolution of traumatic parenchymal intracranial hematomas (ICHs): Comparison of high density and low density components and relationship to outcome.
02:00 PM - 06:30 PM Abstract 167 - Characterization of Baseline EEG Abnormalities the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) Study (BIMA)
Christopher S. Williams, DO, MPH
02:00 PM - 06:30 PM Abstract 168 - Induced Normothermia in Severe Traumatic Brain Injury Patients
02:00 PM - 06:30 PM Abstract 169 - Barriers to Recovery from Concussion
Teena Shetty, MD, FAAN
02:00 PM - 06:30 PM Abstract 170 - Multiple Past Concussions in High School Athletes with ADHD
02:00 PM - 06:30 PM Abstract 172 - Predictors of Outcome in Status Epilepticus in the Neuro ICU
Jules Osias, MD
02:00 PM - 06:30 PM Abstract 173 - Early mobility program in the neurocritical care unit- appropriateness of referral for physical therapy
Laura Bishop, DO
02:00 PM - 06:30 PM Abstract 174 - Psychiatric Symptoms as a Predictor of Outcome in Patients with Post-Concussive Syndrome
Arun S. Chhabra, MD
02:00 PM - 06:30 PM Abstract 175 - Efficacy of Minocycline in Female Rats after Mild Diffuse Traumatic Brain Injury
L. C. Turtzo, MD, PhD
02:00 PM - 06:30 PM Abstract 176 - Knowledge, Awareness, and Attitudes Regarding Concussion among Middle Schoolers
Thor S. Stead
02:00 PM - 06:30 PM Abstract 177 - Neurologic Exam Findings and Clinical Manifestations of Post-Concussion Syndrome in a Pediatric Population
Devon Cohen, MD
02:00 PM - 06:30 PM Abstract 178 - EEG monitoring in patients with hypothermia post cardiac arrest - a comparison of 'evolving' patterns and outcomes
Kushak Suchdev, MD
02:00 PM - 06:30 PM Abstract 179 - Pathological Correlation of Diffusion Tensor Imaging and Magnetization Transfer Biomarkers in a Preclinical Model of Mild Traumatic Brain Injury
Rashida A. Williams
02:00 PM - 06:30 PM Abstract 180 - Correlations of Focal Lesion Volume with Intracranial Hypertension and Brain Tissue Hypoxia after severe Traumatic Brain Injury (TBI)
Leah Harburg
02:00 PM - 06:30 PM Abstract 181 - Observed Specific Pattern of cognitive impairment in patients with Mild Traumatic Brain Injury: a prospective study of 35 patients
02:00 PM - 06:30 PM Abstract 182 - Determining Inter-rater Reliability of Eye Tracking Methods for Use With Persons With Severe Traumatic Brain Injury
02:00 PM - 06:30 PM Abstract 183 - An fMRI-Based Visual Cognition Paradigm for Detection of Command-Following and Communication
02:00 PM - 06:30 PM Abstract 184 - Effect of Lesion Burden on Recovery and on Response to Amantadine in Patients with Disorders of Consciousness after Traumatic Brain Injury
Douglas I. Katz, MD, FAAN
02:00 PM - 06:30 PM Abstract 185 - Montreal Cognitive Assessment, a screening tool for Mild Traumatic Brain Injury
Suresh Kumar, MD
02:00 PM - 06:30 PM Abstract 186 - The Relationship between Cognitive Reserve and Neuropsychological Outcomes after TBI.
Uzma Hussain, MD
02:00 PM - 06:30 PM Abstract 187 - 'From Start-Up-to-CEO': Fostering Guided Experiential Learning of Goal-Oriented Attention Regulation through Game-Assisted Training following Brain Injury
02:00 PM - 06:30 PM Abstract 188 - Cognitive Reserve and Preservation of Functioning Following Traumatic Brain Injury
Jacob Leary
02:00 PM - 06:30 PM Abstract 189 - fMRI-Based Detection of Covert Command-Following and Communication in a Patient with Severe Traumatic Brain Injury
02:00 PM - 06:30 PM Abstract 190 - Despite Initial Moribund Appearance, Critically Ill Traumatic Brain Injury Patients with Diffuse Axonal Injury Have Improved Survival
Susanne Muehlschlegel, MD, MPH, FAAN
02:00 PM - 06:30 PM Abstract 191 - Non-motor Symptoms in patients with SPG4 mutations
02:00 PM - 06:30 PM Abstract 192 - Investigating Exercise as an Approach to Remodeling Motor Unit Fibre Type in Amyotrophic Lateral Sclerosis
Alyson Plecash, MD
02:00 PM - 06:30 PM Abstract 193 - Title: Sit to Stand (STS) - Maneuver: Construct Validity of a Novel Measure of Lower Extremity (LE) Function in ALS Patients
Mohammed S. Sanjak, PhD
02:00 PM - 06:30 PM Abstract 194 - Kinematic Analysis of Arm Reaching Movements in Diverse Neurologic Populations
Christine Kang
02:00 PM - 06:30 PM Abstract 195 - Balance-Based Torso-Weighting (BBTW): A Novel therapy to prevent falls in patients with peripheral neuropathy.
Hasan Askari, MD
02:00 PM - 06:30 PM Abstract 196 - Action Observation and Mirror Neuron System Recruitment: Effect of Type of Task on Motor Facilitation
02:00 PM - 06:30 PM Abstract 197 - Plasticity of Sensorimotor System Induced by Sustained Pressure Stimulation According to Vojta Therapy
Pavel Hok, MD
02:00 PM - 06:30 PM Abstract 198 - Efficacy Results of the Phase 2 Portion of the RADIANCE Trial: A Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 in Adults with Relapsing Multiple Sclerosis
Giancarlo Comi, MD
02:00 PM - 06:30 PM Abstract 199 - Safety and Tolerability Results of the Phase 2 Portion of the RADIANCE Trial: A Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
Krzysztof W. Selmaj
02:00 PM - 06:30 PM Abstract 200 - Interim Analysis of a Phase I Clinical Trial Investigating Intrathecal Administration of Mesenchymal Stem Cell-Neural Progenitors in Multiple Sclerosis
Violaine K. Harris, PhD
02:00 PM - 06:30 PM Abstract 201 - Baseline Demographics and Disease Characteristics from OPERA I and II, Two Phase III Trials Evaluating Ocrelizumab in Patients with Relapsing Multiple Sclerosis
Stephen L. Hauser, MD
02:00 PM - 06:30 PM Abstract 202 - Efficacy Analysis of the Anti-LINGO-1 Monoclonal Antibody BIIB033 in Acute Optic Neuritis: the RENEW Trial
Diego Cadavid, MD, FAAN
02:00 PM - 06:30 PM Abstract 203 - Safety and Tolerability of Anti-LINGO-1 Monoclonal Antibody BIIB033 in Acute Optic Neuritis: the RENEW trial
02:00 PM - 06:30 PM Abstract 204 - BIIB033, Anti-LINGO-1 Antibody, for Treatment of Relapsing Forms of Multiple Sclerosis: Baseline Data of the Phase 2 SYNERGY Trial
Diego Cadavid, MD, FAAN
02:00 PM - 06:30 PM Abstract 205 - Disease activity during the first year predicts clinical long-term outcomes: impact of fingolimod in the TRANSFORMS phase III trial and its extension
Pavle Repovic, MD, PhD
02:00 PM - 06:30 PM Abstract 206 - Effect of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a on Conversion to Multiple Sclerosis (MS) in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III, Double-blind, Multicenter Trials (REFLEX/REFLEXION)
Mark S. Freedman, MD, FAAN
02:00 PM - 06:30 PM Abstract 207 - Multi-center, randomized, double-blinded assessment of dimethyl fumarate in extending the time to a first attack in radiologically isolated syndrome (RIS) (ARISE Trial)
Darin T. Okuda, MD, FAAN
02:00 PM - 06:30 PM Abstract 208 - Analysis of Efficacy by Multifocal Visual Evoked Potentials in Subjects Treated with the Anti-LINGO-1 Monoclonal Antibody BIIB033 in Acute Optic Neuritis: the RENEW Trial
Alexandr Klistorner
02:00 PM - 06:30 PM Abstract 209 - Treatment with Daclizumab HYP Improved Disease-Specific Patient-Reported Outcomes Versus Interferon Beta-1a in Multiple Sclerosis in the Phase 3 DECIDE Trial
02:00 PM - 06:30 PM Abstract 210 - ARPEGGIO: A randomized, placebo-controlled study to evaluate oral laquinimod in patients with primary progressive multiple sclerosis (PPMS)
Frederik Barkhof, MD, PhD
02:00 PM - 06:30 PM Abstract 211 - Safety and Immunogenicity of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III, Double-blind, Multicenter Trials (REFLEX/REFLEXION)
Mark S. Freedman, MD, FAAN
02:00 PM - 06:30 PM Abstract 212 - Teriflunomide Shows Consistent Clinical Efficacy on Severe Relapses across Two Phase 3 Trials in Patients with Relapsing forms of Multiple Sclerosis, TEMSO and TOWER
Richard A. Macdonell, MD, FAAN
02:00 PM - 06:30 PM Abstract 213 - Effects of Anti-LINGO-1 Monoclonal Antibody BIIB033 on Vision-Related Quality-of-Life in Subjects with Acute Optic Neuritis: Results from the RENEW Study
Jennifer Petrillo Billet, PhD
02:00 PM - 06:30 PM Abstract 214 - NN 102/SPRINT-MS Phase II Trial of Ibudilast in Progressive MS: Baseline Characteristics
Robert J. Fox, MD, FAAN
02:00 PM - 06:30 PM Abstract 215 - Differential Recovery from Relapse Between Treatment Groups in the CONFIRM Study of Delayed-Release Dimethyl Fumarate
Andrew Chan
02:00 PM - 06:30 PM Abstract 216 - Baseline characteristics of patients enrolled in CONCERTO - a study of 0.6 and 1.2 mg/day oral laquinimod for relapsing-remitting multiple sclerosis
Giancarlo Comi, MD
02:00 PM - 06:30 PM Abstract 217 - Relapse Outcomes in Patients With Multiple Sclerosis Treated With Fingolimod: Subgroup Analyses of Three Phase 3 Fingolimod Trials
Tobias Derfuss, MD
02:00 PM - 06:30 PM Abstract 218 - Patient experience with glatiramer acetate 40 mg/1 mL three-times weekly treatment for relapsing-remitting multiple sclerosis: Results from the GLACIER extension study
Daniel R. Wynn, MD
02:00 PM - 06:30 PM Abstract 219 - A Phase 3b/4 Long-Term Study of Alemtuzumab in Patients With Relapsing-Remitting Multiple Sclerosis: TOPAZ Study Design
Vesna V. Brinar, MD, PhD
02:00 PM - 06:30 PM Abstract 220 - No Evidence of Disease Activity in Patients with Relapsing MS Treated with Interferon Beta-1a SC tiw Versus Interferon Beta-1a IM qw in the EVIDENCE Study
Patricia K. Coyle, MD, FAAN
02:00 PM - 06:30 PM Abstract 221 - Multiple Sclerosis Patients with No Evidence of Disease Activity in the 2-Year AFFIRM Study Have Better Outcomes with Long-term Natalizumab Treatment than Patients Who Had Evidence of Disease Activity in AFFIRM
Paul W. O'Connor, MD
02:00 PM - 06:30 PM Abstract 222 - The 9-Hole Peg Test (9-HPT) Has a Stronger Correlation than the Expanded Disability Status Scale (EDSS) with Patient-Reported Upper Extremity Impairment As Assessed Using ABILHAND in Patients with Secondary Progressive Multiple Sclerosis (SPMS): Analysis of Baseline Data from the ASCEND Study
Daniel D. Mikol, MD, PhD
02:00 PM - 06:30 PM Abstract 223 - 12-Year Clinical Efficacy and Safety Data for Teriflunomide: Results from a Phase 2 Extension Study
Marcelo C. Kremenchutzky, MD, FAAN
02:00 PM - 06:30 PM Abstract 224 - RNFL as a Surrogate Outcome Marker in Patients with Multiple Sclerosis: Design of the OCTiMS study, Baseline Characteristics and OCT Test Reproducibility
Peter A. Calabresi, MD, FAAN
02:00 PM - 06:30 PM Abstract 225 - Long-Term Safety of Daclizumab HYP in Patients with Relapsing-Remitting Multiple Sclerosis: 3-4 Year Results from the SELECTED Extension Study
Ralf Gold, MD
02:00 PM - 06:30 PM Abstract 226 - Long-Term Efficacy of Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis: 3 Year Results from the SELECTED Extension Study
Ernst-Wilhelm Radue, MD
02:00 PM - 06:30 PM Abstract 227 - Long-term Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with RRMS: An Integrated Analysis of DEFINE, CONFIRM, and ENDORSE
Ralf Gold, MD
02:00 PM - 06:30 PM Abstract 228 - Clinical Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis Patients with Highly Active Disease: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
J. Theodore Phillips, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 229 - Long-term Efficacy of Delayed-Release Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis According to Prior Therapy: Integrated Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
Amit Bar-Or, MD, FRCPC
02:00 PM - 06:30 PM Abstract 230 - Safety and Tolerability Results From the DECIDE Study: A Phase 3 Active-Comparator Study of Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis
Krzysztof W. Selmaj
02:00 PM - 06:30 PM Abstract 231 - Efficacy of Delayed-Release Dimethyl Fumarate for RRMS in Prior Interferon Users in the DEFINE and CONFIRM Studies
Oscar Fernandez, MD
02:00 PM - 06:30 PM Abstract 232 - Efficacy of Delayed-Release Dimethyl Fumarate in Multiple Sclerosis Patients with Moderate Disability: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
Michael Hutchinson, MD, PhD
02:00 PM - 06:30 PM Abstract 233 - Effect of Delayed-Release Dimethyl Fumarate on Total Disability Burden in the CONFIRM Study of Relapsing-Remitting Multiple Sclerosis: Area Under the Curve Analysis of Changes from Baseline in Expanded Disability Status Scale Scores
Nuwan Kurukulasuriya, PhD
02:00 PM - 06:30 PM Abstract 234 - Five-Year Follow-up of Delayed-Release Dimethyl Fumarate in RRMS: Integrated Clinical Efficacy Data from the DEFINE, CONFIRM, and ENDORSE Studies
Amit Bar-Or, MD, FRCPC
02:00 PM - 06:30 PM Abstract 235 - Long-term Follow-up of the Safety of Delayed-Release Dimethyl Fumarate in RRMS: Interim Results from the ENDORSE Extension Study.
Carlo Pozzilli
02:00 PM - 06:30 PM Abstract 236 - Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Delayed-Release Dimethyl Fumarate: A Three-Year Interim Analysis of ENDORSE
Mariko Kita, MD
02:00 PM - 06:30 PM Abstract 237 - Comparative utility of different progression metrics in PPMS: re-analysis of the PROMiSe clinical trial dataset
Marcus W. Koch, MD, PhD
02:00 PM - 06:30 PM Abstract 238 - Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience
Jie Li
02:00 PM - 06:30 PM Abstract 239 - Disease activity in the first year predicts longer-term clinical outcomes in the pooled population of the phase III FREEDOMS and FREEDOMS II studies
Aaron L. Boster, MD
02:00 PM - 06:30 PM Abstract 240 - Rationale for EDSS-Plus, the Primary Composite Endpoint of Disability Progression in the ASCEND Phase 3 Study of Natalizumab for Secondary Progressive Multiple Sclerosis: A Post Hoc Analysis of IMPACT Study Data
Daniel D. Mikol, MD, PhD
02:00 PM - 06:30 PM Abstract 241 - Clinical Effectiveness and Impact on Patient-Reported Outcomes of Delayed-Release Dimethyl Fumarate in Relapsing Multiple Sclerosis Patients After Suboptimal Response to Glatiramer Acetate: A Prospective, Multicenter, Open-Label, Single-Arm, Observational Study (RESPOND)
Kiren Kresa-Reahl, MD
02:00 PM - 06:30 PM Abstract 242 - 1-Year Efficacy and Tolerability Results for IFN Beta-1a SC tiw Treatment and Predictive Value of 6-Month MRI: Exploratory Analysis of PRISMS Data in Patients with RRMS
Mark C. Cascione, MD
02:00 PM - 06:30 PM Abstract 243 - Sustained Low Rate of Brain Volume Loss under Long-term Delayed-Release Dimethyl Fumarate Treatment in Relapsing-Remitting Multiple Sclerosis Patients: Results from the ENDORSE Study
Ludwig Kappos, MD, FAAN
02:00 PM - 06:30 PM Abstract 244 - Natalizumab Reduces Total Disability Burden Relative to Placebo in Patients with Relapsing-Remitting Multiple Sclerosis Regardless of the Occurrence of Relapses or Confirmed Disability Progression or Improvement over 2 Years in the AFFIRM Study
02:00 PM - 06:30 PM Abstract 245 - The effect of fingolimod on T1-hypointense lesions developed on-study and evolution of pre-existing Gd+ lesions, stratified by lesion size: A posthoc analysis of FREEDOMS study
02:00 PM - 06:30 PM Abstract 246 - Durable Effect of Alemtuzumab on MRI Activity in Treatment-Naive Active Relapsing-Remitting Multiple Sclerosis Patients: 4-Year Follow-up of CARE-MS I
Douglas L. Arnold, MD, FAAN
02:00 PM - 06:30 PM Abstract 247 - Effect of Delayed-Release Dimethyl Fumarate on No Evident Disease Activity in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis Patients: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
02:00 PM - 06:30 PM Abstract 248 - Switching to Alemtuzumab From Subcutaneous Interferon Beta-1a After CARE-MS II Further Improved MRI Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis
Daniel Pelletier, MD
02:00 PM - 06:30 PM Abstract 249 - Durable Effect of Alemtuzumab on MRI Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Who Relapsed on Prior Therapy: 4-Year Follow-up of CARE-MS II
Anthony Traboulsee, MD
02:00 PM - 06:30 PM Abstract 250 - Effect of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a on MRI Lesion and Brain Volume Changes in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III REFLEX Study Extension (REFLEXION)
Frederik Barkhof, MD, PhD
02:00 PM - 06:30 PM Abstract 251 - Development of Chronic Black Holes (CBH) Predicts Long Term Disability: Post-hoc Analysis of Magnetic Resonance Imaging (MRI) Data in the PRISMS Study
Anthony Traboulsee, MD
02:00 PM - 06:30 PM Abstract 252 - Daclizumab HYP Reduced Brain MRI Lesion Activity Compared With Interferon Beta-1a: Results from the DECIDE Study
John W. Rose, MD, FAAN
02:00 PM - 06:30 PM Abstract 253 - Positive MRI Outcomes in Patients with Early Multiple Sclerosis Treated with Teriflunomide: Subgroup Analyses from the TOPIC Phase 3 Study
Aaron E. Miller, MD, FAAN
02:00 PM - 06:30 PM Abstract 254 - Early Onset and Predictive Value of MRI Measures among Patients Receiving Interferon Beta-1a SC tiw for RRMS: Post Hoc Analyses of PRISMS-2 Data
02:00 PM - 06:30 PM Abstract 255 - MRI indicators of brain tissue loss: 3-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study in relapsing-remitting multiple sclerosis
Robert Zivadinov, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 256 - In Relapsing Multiple Sclerosis, Peginterferon Beta-1a Reduces MRI Lesions Following Relapses
02:00 PM - 06:30 PM Abstract 257 - Early Effects of Interferon Beta-1a SC tiw Versus Interferon Beta-1a IM qw on MRI Outcomes in Patients with Relapsing MS in the EVIDENCE Study
Anthony Reder, MD
02:00 PM - 06:30 PM Abstract 258 - Long-term MRI follow-up of patients in the ALLEGRO study: results from the yearly frequent MRI sub-cohort
Maria A. Rocca
02:00 PM - 06:30 PM Abstract 259 - Smaller baseline brain volume and higher atrophy rate over two years is associated with poorer clinical outcomes: post hoc analysis of the MS-STAT trial in Secondary Progressive MS
Jeremy S. Chataway, MD
02:00 PM - 06:30 PM Abstract 260 - Natalizumab-Treated Patients with Multiple Sclerosis Have Low Rates of Brain Volume Decrease and Low MRI Disease Activity in the Long-term STRATA Study
Andrew D. Goodman, MD, FAAN
02:00 PM - 06:30 PM Abstract 261 - Switching to Alemtuzumab From Subcutaneous Interferon Beta-1a After CARE-MS I Further Improved MRI Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis
Frederik Barkhof, MD, PhD
02:00 PM - 06:30 PM Abstract 262 - Five-Year Follow-up of Delayed-Release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis: MRI Outcomes from DEFINE, CONFIRM, and ENDORSE
02:00 PM - 06:30 PM Abstract 263 - Alemtuzumab Slows Brain Volume Loss Over 4 Years Despite Most Relapsing-Remitting Multiple Sclerosis Patients Not Receiving Treatment for 3 Years
Alasdair Coles, MD, PhD
02:00 PM - 06:30 PM Abstract 264 - Slowing of Brain Volume Loss in Patients With Relapsing-Remitting Multiple Sclerosis After Switching From Subcutaneous Interferon Beta-1a to Alemtuzumab
Jeffrey A. Cohen, MD
02:00 PM - 06:30 PM Abstract 265 - Incidence of Infection Decreases Over Time in Alemtuzumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis: 4-Year Follow-up of the CARE-MS Studies
Lily J. Henson, MD, MMM, FAAN
02:00 PM - 06:30 PM Abstract 266 - Long-Term Efficacy in MRI and No Evidence of Disease Activity Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Peginterferon Beta-1a
Douglas L. Arnold, MD, FAAN
02:00 PM - 06:30 PM Abstract 267 - The Efficacy of Peginterferon Beta-1a in Early and Later-Stage Patients With Multiple Sclerosis: A 1-Year Subgroup Analysis Based on Disease Duration from the ADVANCE Study
02:00 PM - 06:30 PM Abstract 268 - Pooled Safety Analyses from Teriflunomide Clinical Studies
Thomas Leist, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 269 - Durable Efficacy of Alemtuzumab in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis Who Relapsed on a Prior Therapy
Barry A. Singer, MD
02:00 PM - 06:30 PM Abstract 270 - Improvement in Clinical Outcomes in Treatment-Naive Relapsing-Remitting Multiple Sclerosis Patients Who Switched From Subcutaneous Interferon Beta-1a to Alemtuzumab
Hans-Peter Hartung, MD, FAAN
02:00 PM - 06:30 PM Abstract 271 - No Evidence of Disease Activity in Patients with Relapsing MS Treated with Interferon Beta-1a SC tiw versus Interferon Beta-1a IM qw: Subgroup Analyses of the EVIDENCE Study
Juanzhi Fang
02:00 PM - 06:30 PM Abstract 272 - The Efficacy of Alemtuzumab Is Maintained in Patients Who Develop Thyroid Adverse Events
Samuel F. Hunter, MD, PhD
02:00 PM - 06:30 PM Abstract 273 - Efficacy and safety of a three-times weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study
Omar A. Khan, MD, PhD
02:00 PM - 06:30 PM Abstract 274 - Efficacy of Teriflunomide in Early-Stage MS: Reanalysis of the TOPIC Study Using 2010 McDonald Diagnostic Criteria
Flavia Nelson, MD
02:00 PM - 06:30 PM Abstract 275 - Safety and Efficacy of Teriflunomide in Patients Switching from Subcutaneous Interferon Beta-1a
Jerome De Seze
02:00 PM - 06:30 PM Abstract 276 - Durable Effect of Alemtuzumab on Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Who Relapsed on Prior Therapy: 4-Year Follow-up of CARE-MS II
Eva Havrdova, MD
02:00 PM - 06:30 PM Abstract 277 - Administration of Alemtuzumab on Nonconsecutive Days Does Not Impact Infusion-Associated Reactions, Efficacy, or Lymphocyte Depletion
Sibyl E. Wray, MD
02:00 PM - 06:30 PM Abstract 278 - Improvement in Clinical Outcomes Following Switch From Subcutaneous Interferon Beta-1a to Alemtuzumab: CARE-MS II Extension Study
Edward Fox, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 279 - Teriflunomide Significantly Increased Time to First Relapse in TEMSO, TOWER and TOPIC
William D. Honeycutt, MD
02:00 PM - 06:30 PM Abstract 280 - Long-term Follow-up of the Effect of Delayed-Release Dimethyl Fumarate on No Evidence of Disease Activity in Patients with Multiple Sclerosis
Gavin Giovannoni, MD
02:00 PM - 06:30 PM Abstract 281 - Design of a Non-interventional Study to Establish Effectiveness, Quality of Life, Cognition, Health-Related and Work Capacity Data on Alemtuzumab in Multiple Sclerosis Patients in Germany (TREAT-MS)
02:00 PM - 06:30 PM Abstract 282 - Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients
Jean Pelletier, MD, PhD
02:00 PM - 06:30 PM Abstract 283 - Evaluation of Comprehensive Alemtuzumab Infusion Guidance in Patients With Relapsing-Remitting Multiple Sclerosis: EMERALD Study Design
Patrick Vermersch
02:00 PM - 06:30 PM Abstract 284 - Normalized brain volume predicts cognitive performance in MS: an analysis of a large cohort from fingolimod phase III studies
Maria Pia Sormani
02:00 PM - 06:30 PM Abstract 285 - Early neurological worsening in Wilson’s Disease patients.
Anna Czlonkowska, MD
02:00 PM - 06:30 PM Abstract 286 - Complementary medicine and cannabis use by Parkinson’s Disease patients in Colorado
Taylor A. Finseth, MD
02:00 PM - 06:30 PM Abstract 287 - Description of a New Rapid-Access Clinic for Parkinson’s Disease Patients: the Navigator Model
02:00 PM - 06:30 PM Abstract 288 - Typical, atypical and vascular parkinsonism in Jamaica: an 8-year prospective study
Amza Ali, MD, FRCP, FAAN
02:00 PM - 06:30 PM Abstract 289 - More severe parkinsonism is associated with lower physical activity-related energy expenditure in PD
Jonathan D. Snider, MD, FAAN
02:00 PM - 06:30 PM Abstract 290 - Neurologic Manifestations of Lesch Nyhan Syndrome Improved with Bilateral Deep Brain Stimulation, a Case Report
Ramsey A. Falconer, MD, FAAN
02:00 PM - 06:30 PM Abstract 291 - Neurodegeneration and Brain Iron Accumulation disorders in Hungary: genotype-phenotype analysis
Maria J. Molnar, MD, PhD
02:00 PM - 06:30 PM Abstract 292 - Neuroborreliosis Parkinsonism and Rapid Eye Movement Sleep Behavior Disorder
Katherine Werbaneth
02:00 PM - 06:30 PM Abstract 293 - Systematic review of Parkinson’s disease related mobile applications
Dronacharya Lamichhane, MD
02:00 PM - 06:30 PM Abstract 294 - The Effect of Gabapentin Enacarbil (GEn) on Pain Outcomes in Adults with Moderate-to-Severe and Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses from 3 Randomized Controlled Trials
Neal S. Hermanowicz, MD, FAAN
02:00 PM - 06:30 PM Abstract 295 - Incobotulinum toxin-A (inco-A) in restless legs syndrome (RLS) - a randomized double blind cross over study
Rezvan Rostami, MD
02:00 PM - 06:30 PM Abstract 296 - RESTIFFIC, a unique pressure foot wrap, is more effective than a dopamine agonist in reducing the symptoms of moderate to severe Restless Leg Syndrome
John P. Sullivan, MD
02:00 PM - 06:30 PM Abstract 297 - Restless Limb Syndrome(RLS)and Bruxism: A Subgroup Analysis and Dose-response Data
David J. Dickoff, MD
02:00 PM - 06:30 PM Abstract 298 - Rotigotine in Patients with Restless Legs Syndrome and End-stage Renal Disease Requiring Hemodialysis
John Winkelman, MD, PhD
02:00 PM - 06:30 PM Abstract 299 - The Effect of Gabapentin Enacarbil (GEn) on Quality-of-Life (QoL) Outcomes in Adult Patients With Moderate-to-Severe and Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses From Two 12-Week Trials
Alon Y. Avidan, MD, MPH, FAAN
02:00 PM - 06:30 PM Abstract 300 - The Effect of Gabapentin Enacarbil (GEn) on Mood Outcomes in Adult Patients With Moderate-to-Severe and Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses from Three 12-Week Trials
Daniel Lee, MD, FAAN
02:00 PM - 06:30 PM Abstract 301 - Prevalence of Restless Legs Syndrome in an Atypical Parkinson's Disease Patient Population
Jose-Rafael P. Zuzuarregui, MD
02:00 PM - 06:30 PM Abstract 302 - Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease.
Corneliu C. Luca, MD
02:00 PM - 06:30 PM Abstract 303 - Hyperdopaminergism in Lenticulostriate Stroke-Induced Restless Legs Syndrome: A Neuro Imaging Study
02:00 PM - 06:30 PM Abstract 304 - First 1-year Real-life Study to Assess Management of Augmentation of Restless Legs Syndrome by Switching to Rotigotine Transdermal System
Claudia Trenkwalder, MD
02:00 PM - 06:30 PM Abstract 305 - Impulse Control Disorders are associated with REM Sleep Behavior Disorder in patients with Parkinson’s Disease: a Video-Polysomnographic Study
Maria Livia Fantini
02:00 PM - 06:30 PM Abstract 306 - REM Sleep Behavior Disorder: How Useful is it for the Differential Diagnosis of Parkinsonism?
Helio Afonso G. Teive, MD, PhD, FAAN
02:00 PM - 06:30 PM Abstract 307 - REM Sleep without Atonia Severity Predicts Cognitive Impairment in REM Sleep Behavior Disorder
David Sandness, MD
02:00 PM - 06:30 PM Abstract 308 - Aggression in Nightmares and Unpleasant Dreams and in People Reporting Recurrent Nightmares
April Minsky
02:00 PM - 06:30 PM Abstract 309 - Improving Knowledge of ICSD-3 and DSM-5 Criteria for Diagnosing Narcolepsy
02:00 PM - 06:30 PM Abstract 310 - Pain and Sleep Disturbance in the Elderly: Evaluation the Role of Stress and Depression
Victor Lami, MD
02:00 PM - 06:30 PM Abstract 311 - Cross-Cultural Chronotypes: Medical Students in America, Malaysia and the UAE
Nicoline Schiess, MD
02:00 PM - 06:30 PM Abstract 312 - Are periodic leg movements increased in the painful restless legs syndrome?
Elias G. Karroum, MD
02:00 PM - 06:30 PM Abstract 314 - The Alteration of Cyclic Alternating Pattern in Obstructive Sleep Apnea Syndrome with and without Excessive Daytime Sleepiness
Selda Korkmaz, MD
02:00 PM - 06:30 PM Abstract 315 - Clinically Moderate to Severe Insomnia without Excessive Daytime Sleepiness in Diabetic Patients with Chronic Neuropathic Limb Pain
Martin Rakusa, MD
02:00 PM - 06:30 PM Abstract 317 - An Ambulatory Treatment Pathway Expedites the Diagnosis and Treatment of Sleep Apnea after Cerebrovascular Events
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc
02:00 PM - 06:30 PM Abstract 318 - Is Traumatic Brain Injury Associated with PAP Adherence in Obstructive Sleep Apnea: A Pilot Study.
Lynn Kataria, MD
02:00 PM - 06:30 PM Abstract 319 - Sleep and Concussion Review and Evaluation (SCORE): Sleep Disorders in Pediatric Sports-Related Concussions
Ping-Ru T. Ko, MD
02:00 PM - 06:30 PM Abstract 320 - Sleep macrostructure and microstructure in acute and chronic spinal cord injury patients
Pietro Guaraldi, MD, PhD
02:00 PM - 06:30 PM Abstract 321 - Implementing a Clinical iPad Application to Detect Sleep Disorders is Feasible Across Multiple Non-Sleep Outpatient Clinics
Ankur Doshi
02:00 PM - 06:30 PM Abstract 322 - Assessment of the Timeliness of Administration of Second Line Antiepileptic Drugs for Status Epilepticus after the Implementation of a Status Epilepticus Bundle Order Set: A Single Institution Experience
Mark A. Callow, MD
02:00 PM - 06:30 PM Abstract 323 - Impact of EEG Laboratory Resources and Timeliness of Initiation of Continuous Video-EEG Monitoring: A Single Institution Experience.
Mark A. Callow, MD
02:00 PM - 06:30 PM Abstract 324 - Physician Communication About Driving Restrictions After Episodic Loss of Consciousness
Natalie C. Wheeler, MD
02:00 PM - 06:30 PM Abstract 325 - Patient Perspectives on Physician Compensation and Conflict of Interest in Industry-Sponsored Clinical Trials for Multiple Sclerosis
Andrew Solomon, MD, FAAN
02:00 PM - 06:30 PM Abstract 326 - An analysis of after hours MRI scans in a busy tertiary hospital neuro intensive care unit-Does your patient safety is at jeopardy?
Premkumar Nattanmai Chandrasekaran, MD
02:00 PM - 06:30 PM Abstract 327 - Diagnostic Imaging Delays and Efforts to Minimize for Neurology Patients in the Hospital Setting
Ryan Crooks, MD
02:00 PM - 06:30 PM Abstract 328 - PDSA Cycle and Implementation of World-wide Best Practices to Achieve Faster Door to Needle
Waimei A. Tai, MD, FAAN
02:00 PM - 06:30 PM Abstract 329 - Stroke care cost variability between physicians at a comprehensive stroke center is low
Michael Dobbs, MD
02:00 PM - 06:30 PM Abstract 330 - Standardizing Stroke Evaluation in the Cardiac Catheterization Lab: Aldrete-FAST Score
Michelle C. Johansen, MD
02:00 PM - 06:30 PM Abstract 331 - A survey and intervention to improve effective communication between Critical care team and Neurology team in a busy neurointensive care unit-A portal to improve patient care.
Premkumar Nattanmai Chandrasekaran, MD
02:00 PM - 06:30 PM Abstract 333 - A Quantitative Evaluation of Undisclosed Conflicts of Interest in Neuropsychopharmacology, General Pharmacology, and Pharmacotherapy Textbooks
Brian J. Piper, PhD
02:00 PM - 06:30 PM Abstract 335 - Neurohospitalist billing practices compared to Hospital Medicine
Pearce J. Korb, MD, FAAN
02:00 PM - 06:30 PM Abstract 337 - A quality improvement strategy for documenting last pyridostigmine dose prior to the performance of nerve conduction studies/electromyography
Amy C. Visser, MD
02:00 PM - 06:30 PM Abstract 338 - Spatiotemporal gait parameters as a potential outcome measure for CIDP
Russell L. Chin, MD
02:00 PM - 06:30 PM Abstract 340 - Documentation of Advance Healthcare Planning in the Electronic Health Records of Elderly Out-Patients with Dementia or Cognitive Impairment
Kendra Peterson, MD
02:00 PM - 06:30 PM Abstract 341 - Choice of Initial Pharmacotherapy Treatment in Older Adults with Parkinson’s Disease: Associations with Health Outcomes
Elizabeth J. Grubb, PhD
02:00 PM - 06:30 PM Abstract 342 - Quality measures in Parkinson Disease: Assessment of frequency of documenting quality measures in PD
Sarah Pirio Richardson, MD, FAAN
02:00 PM - 06:30 PM Abstract 343 - A Retrospective Review of Amyotrophic Lateral Sclerosis Patients and Adherence to 好色先生's Practice Parameter
Rashmi Rao, MD
Faculty Disclosures
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
George Howard, PhD Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Omar A. Khan, MD, PhD No disclosure on file
Ari Green, MD Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
J. Theodore Phillips, MD, PhD, FAAN No disclosure on file
No disclosure on file
Anita T. Wu, MD No disclosure on file
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Merit E. Cudkowicz, MD, MSC, FAAN Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Rachel Marie E. Salas, MD, MEd, FAAN Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Calixto Machado, MD, PhD, FAAN Dr. Machado has nothing to disclose.
Travis E. Losey, MD No disclosure on file
Mark A. Ross, MD, FAAN No disclosure on file
Richard K. Kim, MD Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Aaron Ellenbogen, DO Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Nobutoshi Kawamura No disclosure on file
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Raju Kapoor, MD No disclosure on file
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Amanda C. Peltier, MD, MS Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.
Daniel Sanak No disclosure on file
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Finn Sellebjerg, MD Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
George Grossberg, MD Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karuna. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Grossberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newron. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oligomerix. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quince. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. The institution of Dr. Grossberg has received research support from NIA. The institution of Dr. Grossberg has received research support from Functional Neuromodulation .
Michael D. Weiss, MD, FAAN Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Kyle B. Womack, MD The institution of Dr. Womack has received research support from NIH. The institution of Dr. Womack has received research support from Janssen.
Michael H. Rivner, MD, FAAN No disclosure on file
Philippe Ryvlin, MD, PhD Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle/Angelini. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. The institution of Dr. Ryvlin has received research support from Swiss National Fund. The institution of Dr. Ryvlin has received research support from European Commission (Horizon Europe).
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Richard M. Dubinsky, MD, MPH, FAAN Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to AAN interests or activities.
Bernadette Kalman, MD, PhD, Dsc, FAAN, FAAN No disclosure on file
Michael A. Panzara, MD, MPH Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi.
Alasdair Coles, MD, PhD Dr. Coles has nothing to disclose.
Jeffrey M. Burns, MD Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Liana Apostolova, MD, FAAN Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for siemens. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. Dr. Apostolova has a non-compensated relationship as a advisor with FDA that is relevant to AAN interests or activities.
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Javier Olazaran, MD No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Patrick McNamara, PhD No disclosure on file
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Julieta V. Mazziotti, MD No disclosure on file
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Frederick W. Unverzagt, PhD No disclosure on file
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Eric M. McDade, DO Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche-Genentech. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer.
Wojciech Kozubski, MD, PhD No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Allison L. Weathers, MD, FAAN Dr. Weathers has received personal compensation in the range of $500-$4,999 for serving as a CME question writer, interviewer, presenter with 好色先生. Dr. Weathers has a non-compensated relationship as a Chair, Neurology Adult Steering Board with Epic that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member, Quality Informatics Subcommittee with 好色先生 that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member of the NCP Editorial Board with 好色先生 that is relevant to AAN interests or activities.
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Alastair Compston, PhD, FRCP No disclosure on file
Seemant Chaturvedi, MD, FAHA, FAAN Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Erica Harris No disclosure on file
Eric J. Sorenson, MD, FAAN The institution of Dr. Sorenson has received research support from Biogen.
Christopher M. Filley, MD, FAAN Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Patricia K. Coyle, MD, FAAN Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Vissia Viglietta, MD No disclosure on file
Joseph Nguyen, DO Dr. Nguyen has nothing to disclose.
Anne L. Lafontaine, MD Dr. Lafontaine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin. Dr. Lafontaine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Lafontaine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie.
Richard P. Allen, PhD No disclosure on file
Neal S. Hermanowicz, MD, FAAN No disclosure on file
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
A. Gordon Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
John Winkelman, MD, PhD John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. John Winkelman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Azurity. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Disc Medicine. An immediate family member of John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noctrix. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Psychogenics. The institution of John Winkelman has received research support from American Regent. The institution of John Winkelman has received research support from Merck. John Winkelman has received publishing royalties from a publication relating to health care. John Winkelman has a non-compensated relationship as a Chair with International Restless Legs Syndrome Study Group that is relevant to AAN interests or activities. John Winkelman has a non-compensated relationship as a Member with Restless Legs Syndrome Foundation Scientific Medical Advisory Board that is relevant to AAN interests or activities.
Anthony Chen, MD No disclosure on file
Steve Chung, MD, FAAN The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Koichi Okamoto, MD, PhD No disclosure on file
Mohammad Alsharabati, MD No disclosure on file
Andrea N. Leep Hunderfund, MD The institution of Dr. Leep Hunderfund has received research support from American Medical Association. The institution of Dr. Leep Hunderfund has received research support from Kern National Network for Caring and Character in Medicine. Dr. Leep Hunderfund has received intellectual property interests from a discovery or technology relating to health care.
Yasuo Iwasaki, MD No disclosure on file
Volker A. Knappertz, MD Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Wazim Mohamed, MD Dr. Mohamed has nothing to disclose.
Marco A. Rizzo, MD, PhD No disclosure on file
Stephan A. Mayer, MD Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Alrabi Tawil, MD, FAAN Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for meRicule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care.
Jouko I. Isojarvi, MD, PhD No disclosure on file
Maria J. Molnar, MD, PhD Dr. Molnar has nothing to disclose.
Amanda L. Deligtisch, MD, FAAN No disclosure on file
Christiana E. Hall, MD No disclosure on file
Klaus Schmierer, MD, PhD Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Raphael A. Carandang, MD, FAAN Dr. Carandang has nothing to disclose.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
James L. Bernat, MD, FAAN Dr. Bernat has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Physician's Index for Ethics in Medicine. The institution of Dr. Bernat has received research support from National Institutes of Health UL1TR001086. The institution of Dr. Bernat has received research support from National Institutes of Health ME-1609-36174. Dr. Bernat has received publishing royalties from a publication relating to health care.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Peter Rieckmann, MD, FAAN No disclosure on file
Nicolaas I. Bohnen, MD, PhD, FAAN Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Gustavo Alva, MD Dr. Alva has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Alva has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurocrine. The institution of Dr. Alva has received research support from Neurocrine.
Patricia M. Riccio, MD No disclosure on file
John M. Ringman, MD, FAAN The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Robert T. Wechsler, MD, PhD, FAAN The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Craig M. Zaidman, MD Dr. Zaidman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sarepta. The institution of Dr. Zaidman has received research support from Washington University in St Louis. The institution of Dr. Zaidman has received research support from Novartis.
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Namita Goyal, MD, FAAN Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Sandra E. Black, MD, FAAN Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Tamara Vyshkina, PhD No disclosure on file
Alfredo Thomson, MD Dr. Thomson has nothing to disclose.
Margaret Park, MD No disclosure on file
Alon Y. Avidan, MD, MPH, FAAN Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.
Nicholas J. Silvestri, MD, FAAN Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of an immediate family member of Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Silvestri has received publishing royalties from a publication relating to health care.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Andrew M. Southerland, MD, FAAN Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Petr Hlustik, MD, PhD The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Daniel Lee, MD, FAAN No disclosure on file
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Ryosuke Takahashi, MD Dr. Takahashi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kan Institute. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharma. Dr. Takahashi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ono Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenix. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnyrum. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo Pharma. The institution of Dr. Takahashi has received research support from MEXT. Japan. The institution of Dr. Takahashi has received research support from AMED, Japan. The institution of Dr. Takahashi has received research support from JST, Japan. The institution of Dr. Takahashi has received research support from MHLW, Japan. The institution of Dr. Takahashi has received research support from Sumitomo Pharma. The institution of Dr. Takahashi has received research support from Takeda Pharma. The institution of Dr. Takahashi has received research support from Otsuka Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a PO with AMED, Japan. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a PO with JST, Japan.
Marianne T. Sweetser, MD, PhD Dr. Sweetser has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Sweetser has received stock or an ownership interest from Alnylam Pharmaceuticals.
Yves Dauvilliers, MD, PhD Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience.
Lei Xu, MD No disclosure on file
Janice M. Massey, MD, FAAN Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
James M. Noble, MD, FAAN Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
W D. Shields, MD No disclosure on file
Alexey Boyko, MD, PhD No disclosure on file
Mohammed S. Sanjak, PhD No disclosure on file
Bum Joon Kim Dr. Kim has nothing to disclose.
Michelle Ghobrial, MD No disclosure on file
Gregory Krauss, MD Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Elliott D. Ross, MD, FAAN No disclosure on file
Jean-Pierre Bouchard, MD, FAAN No disclosure on file
Mohammad Salajegheh, MD, FAAN Dr. Salajegheh has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with US Department of Veterans Affairs. Dr. Salajegheh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with CRICO.
John M. Pellock, MD No disclosure on file
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Linda S. Williams, MD, FAAN The institution of Dr. Williams has received research support from VA HSR&D.
Jason S. Mackey, MD Dr. Mackey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for legal firms. The institution of Dr. Mackey has received research support from PCORI.
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Bridget T. Carey, MD No disclosure on file
Georgia D. Montouris, MD No disclosure on file
Stuart H. Isaacson, MD, FAAN The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Masako Kinoshita, MD, PhD Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharmaceutical Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan Co. Ltd. . Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo Company, Limited.. The institution of Dr. Kinoshita has received research support from Japan Society for the Promotion of Science. The institution of Dr. Kinoshita has received research support from Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering .
Claudia V. Maurer-Morelli, PhD No disclosure on file
Rajesh K. Gupta, MBBS Dr. Gupta has nothing to disclose.
Noah A. Kolb, MD Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abalone Medical. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Kolb has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisana corporation. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NINDS. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Locks Law. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for walk up law office . Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for ralston, pope, diehl. The institution of Dr. Kolb has received research support from National Cancer Institute.
Vladimir Klinov, MD No disclosure on file
Ahmed A. Malik, MD No disclosure on file
Gilles Edan Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Claudia A. Chiriboga, MD, FAAN Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care.
Benn E. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
Keith R. Edwards, MD, FAAN No disclosure on file
Zohar Argov, MD No disclosure on file
Bernhard Hemmer, MD No disclosure on file
Michael Dobbs, MD Dr. Dobbs has received publishing royalties from a publication relating to health care.
Jong S. Kim, MD, PhD No disclosure on file
William D. Honeycutt, MD Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Honeycutt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celegene.
Guojun Zhao, MD No disclosure on file
Joao O. Siffert, MD No disclosure on file
Tiffany Braley, MD Dr. Braley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluestar BioAdvisors. The institution of Dr. Braley has received research support from NIH. The institution of Dr. Braley has received research support from PCORI. The institution of Dr. Braley has received research support from National Multiple Sclerosis Society.
Dinesh Kumar Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Donald B. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Bradford B. Worrall, MD, MSc, FAAN The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
J. R. Singleton, MD Dr. Singleton has received research support from NIH.
Steven J. Greenberg, MD No disclosure on file
Lilit Mnatsakanyan, MD Dr. Mnatsakanyan has nothing to disclose.
Katherine A. Riester, MPH No disclosure on file
John J. Volpi, MD Dr. Volpi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Volpi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for W.L. Gore. Dr. Volpi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Volpi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Volpi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Volpi has received intellectual property interests from a discovery or technology relating to health care.
Vivienne Shen Vivienne Shen has received personal compensation for serving as an employee of Lundbeck.
Michael D. Kaufman, MD No disclosure on file
Patricia G. Barbalho, PhD No disclosure on file
Hidefumi Ito, MD, PhD No disclosure on file
Macaulay Okwuokenye No disclosure on file
Christopher Coffey, PhD, FAAN Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Michael Hutchinson, MD, PhD No disclosure on file
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Rafael Arroyo-Gonzalez No disclosure on file
David H. Margolin, MD, PhD Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from Slamen-Fast New Initiatives in Neurology Award. The institution of Dr. Boulos has received research support from Green Mountain . The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and 好色先生 in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Jazz Pharmaceuticals.
Kenya Murata, MD No disclosure on file
Bertrand Audoin No disclosure on file
Brion D. Reichler, MD No disclosure on file
Marie-Pierre Chaunu No disclosure on file
Leah Shabo No disclosure on file
Mark F. Walker, MD The institution of Dr. Walker has received research support from US Department of Veterans Affairs. Dr. Walker has received publishing royalties from a publication relating to health care. Dr. Walker has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer for Congressionally Directed Medical Research Program with General Dynamics Information Technology.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Scott L. Silliman, MD Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Carlos Singer, MD Dr. Singer has nothing to disclose.
Douglas I. Katz, MD, FAAN Dr. Katz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Katz has received research support from NINDS/NIH. Dr. Katz has received publishing royalties from a publication relating to health care.
Melissa Armstrong, MD, MSc, FAAN, FAAN The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Charles Bernick, MD Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
David P. Richman, MD, FAAN The institution of Dr. Richman has received research support from Muscular Dystrophy Association.
Joel Raskin No disclosure on file
Luigi Maria Grimaldi, MD No disclosure on file
Charlene Gamaldo, MD, FAAN Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Robert C. Burger, MD No disclosure on file
Morenikeji Komolafe, MD Dr. Komolafe has nothing to disclose.
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Emmanuelle Volle No disclosure on file
Amy T. Towfighi, MD Dr. Towfighi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Towfighi has received research support from NIH.
Pietro Cortelli, MD, FAAN Dr. Cortelli has nothing to disclose.
Nicoline Schiess, MD Dr. Schiess has received personal compensation for serving as an employee of World Health Organization .
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Christoph Pohl, MD No disclosure on file
Anna Marisa Cervantes-Arslanian, MD, FAAN Dr. Cervantes-Arslanian has nothing to disclose.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Taofiki A. Sunmonu, MD, FAAN Dr. Sunmonu has nothing to disclose.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Luisa Maria Villar Guimerans, MD No disclosure on file
Sani A. Abubakar No disclosure on file
Matthew Vibbert, MD Dr. Vibbert has nothing to disclose.
Amparo Gutierrez, MD, FAAN Dr. Gutierrez has nothing to disclose.
Claudia Trenkwalder, MD Dr. Trenkwalder has received personal compensation for serving as an employee of Paracelsus-Kliniken. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esteve. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Trenkwalder has received research support from DLR /BMBF. Dr. Trenkwalder has received intellectual property interests from a discovery or technology relating to health care.
Erik P. Pioro, MD, DPhil, FAAN Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Jin J. Luo, MD, PhD, FAAN Dr. Luo has nothing to disclose.
Thomas Brannagan III, MD, FAAN Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Jelena Drulovic Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PharmaSwiss. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actavis TEVA. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medis. Jelena Drulovic has received research support from Ministry of Science, Technological Development and Innovations of the Republic of Serbia.
Benzi Kluger, MD, FAAN Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Neuropalliative Care Society. Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Palliative Medicine. The institution of Dr. Kluger has received research support from NIH. The institution of Dr. Kluger has received research support from PCORI.
Sergiu C. Blumen, MD No disclosure on file
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Sandra Vukusic, MD The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Dennis Chan, MD, PhD, FRCP No disclosure on file
Philippe Truffinet, MD Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
John Corboy, MD, FAAN Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Steven Ferris No disclosure on file
Ramy El Khoury, MD, FAAN No disclosure on file
Nissim Sasson No disclosure on file
Eric E. Adelman, MD The institution of Dr. Adelman has received research support from PCORI.
Giulio Disanto, MD, PhD The institution of Dr. Disanto has received research support from Swiss MS Sociery.
Daniel DiCapua, MD, FAAN Dr. DiCapua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. DiCapua has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Betul B. Gundogdu, MD Dr. Gundogdu has nothing to disclose.
Aaron L. Boster, MD Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Sarah Pirio Richardson, MD, FAAN Dr. Pirio Richardson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Pirio Richardson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. The institution of Dr. Pirio Richardson has received research support from NIH. The institution of Dr. Pirio Richardson has received research support from DOD. The institution of Dr. Pirio Richardson has received research support from Scion. The institution of Dr. Pirio Richardson has received research support from Jazz Pharmaceuticals. The institution of Dr. Pirio Richardson has received research support from UCB. The institution of Dr. Pirio Richardson has received research support from Buk-wang Pharmaceuticals.
Zeina N. Chemali, MD Dr. Chemali has nothing to disclose.
Pavle Repovic, MD, PhD Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Repovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyersSquibb. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Repovic has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. The institution of Dr. Repovic has received research support from Genentech. The institution of Dr. Repovic has received research support from Biogen.
Davorka Tomic Davorka Tomic has stock in Meck KGaA.
Raja S. Boddepalli, MD No disclosure on file
Emily Stern, MD No disclosure on file
Eduardo R. Bendersky, MD No disclosure on file
Matthew B. Freeman, MD No disclosure on file
Yun Chen, PhD No disclosure on file
Anna Czlonkowska, MD Dr. Czlonkowska has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Leonardo Lopiano, MD No disclosure on file
Laura Bishop, DO No disclosure on file
Helena W. Lau No disclosure on file
Paul W. O'Connor, MD No disclosure on file
Robert C. Sergott, MD Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Deepa Bhupali, MD Dr. Bhupali has nothing to disclose.
Bahman Jabbari, MD, FAAN Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Joseph D. Burns, MD Dr. Burns has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Heike Benes No disclosure on file
Olubunmi A. Ogunrin, MD No disclosure on file
Howard S. Rossman, DO No disclosure on file
R E. Faught, Jr., MD, FAAN Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Joseph T. Giacino, PhD The institution of Dr. Giacino has received research support from National Institute on Disability, Independent Living and Rehabilitation Research. The institution of Dr. Giacino has received research support from National Institute on Neurological Disorders and Stroke. The institution of Dr. Giacino has received research support from Department of Defense. The institution of Dr. Giacino has received research support from SameYou Foundation. Dr. Giacino has received intellectual property interests from a discovery or technology relating to health care.
Pravin George, DO Dr. George has nothing to disclose.
Jacob S. Elkins, MD No disclosure on file
David H. Miller, MD, MBChB, FRCP No disclosure on file
Sally Dunaway, DPT Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Nuwan Kurukulasuriya, PhD No disclosure on file
Sebina Bulic, MD Dr. Bulic has nothing to disclose.
Tanya Fischer, MD, PhD No disclosure on file
Michael Lang No disclosure on file
Hans J. Moebius, MD, PhD, FAAN Dr. Moebius has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Athira Pharma, Inc.. Dr. Moebius has stock in Athira Pharma, Inc..
Giuseppe De Scisciolo, MD No disclosure on file
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Helio Afonso G. Teive, MD, PhD, FAAN Dr. Teive has nothing to disclose.
Niels Bergsland Prof. Bergsland has nothing to disclose.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Xiaojun You, PhD No disclosure on file
Michael Silber, MB, ChB, FAAN Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
James F. Burke, MD Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes. The institution of Dr. Burke has received research support from Genentech Foundation. The institution of Dr. Burke has received research support from NIH.
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Pablo Villoslada, MD, PhD, FAAN Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Miguel Ulla, MD, PhD No disclosure on file
Andrew Solomon, MD, FAAN Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Rachana Gandhi, MD Dr. Gandhi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Gandhi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Gandhi has received research support from Akcea Therapeutics. The institution of Dr. Gandhi has received research support from UCB.
Sophia S. Lee, PhD No disclosure on file
Scott D. Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Vojislav Pejovic, PhD No disclosure on file
Kimberly Robeson, MD, FAAN Dr. Robeson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Robeson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Christopher Grunseich, MD The institution of Dr. Grunseich has received research support from AnnJi Pharmaceuticals.
Ramsey A. Falconer, MD, FAAN Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbott. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GE Health. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Acorda. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Federal Trade Comission (FTC). Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Justice Department.
Xiangyi Meng, PhD Dr. Meng has nothing to disclose.
Kendra Peterson, MD No disclosure on file
Stephen A. Figueroa, MD No disclosure on file
Natalie C. Wheeler, MD Dr. Wheeler has nothing to disclose.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Wiley Hall, MD No disclosure on file
Philippe P. Derost No disclosure on file
Bjorn K. Sperling, MD No disclosure on file
Sanford H. Auerbach, MD, FAAN Dr. Auerbach has nothing to disclose.
Fernando Dangond, MD, FAAN Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Calin I. Prodan, MD The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
John Whyte, MD, PhD No disclosure on file
Jhanvi Menon, MD No disclosure on file
Elena Bravver, MD No disclosure on file
Minhua Yang No disclosure on file
Eva-Maria Wicklein, MD Dr. Wicklein has received personal compensation for serving as an employee of Bayer AG.
Haichen Yang, MD No disclosure on file
David Leppert, MD Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Frank A. Imarhiagbe, MD No disclosure on file
Rezvan Rostami, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Oscar Fernandez, MD No disclosure on file
Sujata Sarda, PhD No disclosure on file
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Yun-Fei Chen, PhD No disclosure on file
John Dsurney, PhD, ABPP No disclosure on file
Myla D. Goldman, MD, MSc, FAAN Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Jennifer A. Frontera, MD Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician 好色先生 Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Elizabeth J. Grubb, PhD No disclosure on file
Naomi Feuer, MD No disclosure on file
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Elena Pegoraro, MD, PhD No disclosure on file
Mark Novas No disclosure on file
Suzanne Hendrix, PhD Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Alexander George No disclosure on file
Amrita Amanda D. Vuppala, MD Dr. Vuppala has nothing to disclose.
Kara A. Sands, MD Dr. Sands has nothing to disclose.
Varoon R. Thavapalan, MD No disclosure on file
Ikjae Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Spastic Paraplegia Foundation.
Robert S. Feldman, MD No disclosure on file
Alejandra D. Martinez, MD No disclosure on file
Laura Jardim No disclosure on file
Russell L. Chin, MD No disclosure on file
Drew Velting, PhD No disclosure on file
Yuval Dadon, MD No disclosure on file
Alyana Samai No disclosure on file
Emily Leibovitch No disclosure on file
Sarah J. Rathman, DO Dr. Rathman has nothing to disclose.
Peter Klivenyi, PhD No disclosure on file
Aline Herlopian, MD Dr. Herlopian has nothing to disclose.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Michal Kral No disclosure on file
Norman Latov, MD, PhD Dr. Latov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron. Dr. Latov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therapath LLC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mcaloon & Freeman, PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sylvia Chin-Kaplan, LLC. The institution of Dr. Latov has received research support from Takeda. Dr. Latov has received publishing royalties from a publication relating to health care.
Philipp Albrecht, PhD Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Taha Gholipour, MD Dr. Gholipour has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Flavia Nelson, MD Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Alexandr Klistorner Alexandr Klistorner has nothing to disclose.
Muhammad Ahmed N. Chauhan, MD Dr. Chauhan has nothing to disclose.
Angela Kokkinis Angela Kokkinis has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Maria Livia Fantini No disclosure on file
Arun S. Chhabra, MD Dr. Chhabra has stock in Pfizer. Dr. Chhabra has stock in Biogen. Dr. Chhabra has stock in Johnson and Johnson. Dr. Chhabra has stock in Medtronic.
Peter Acs No disclosure on file
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Suresh Kumar, MD Dr. Kumar has nothing to disclose.
Rajan R. Gadhia, MD Dr. Gadhia has nothing to disclose.
Vladimir Evilevitch No disclosure on file
Jean Pelletier, MD, PhD Dr. Pelletier has nothing to disclose.
Wendy M. King, PT Ms. King has nothing to disclose.
Mona Sazgar, MD Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sazgar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences. The institution of Dr. Sazgar has received research support from UCB. Dr. Sazgar has received publishing royalties from a publication relating to health care.
Wilson Marques, Jr., MD Dr. Marques has nothing to disclose.
Preet M. Varade, MD Dr. Varade has nothing to disclose.
Lydie Crespy No disclosure on file
Leah Harburg No disclosure on file
Mary Ganguli, MD, MPH No disclosure on file
Mei-Sheng Duh, MPH, ScD No disclosure on file
Aashit K. Shah, MD, FAAN Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Stanley Krolczyk, MD No disclosure on file
Pavel Hok, MD Dr. Hok has nothing to disclose.
Hans D. Katzberg, MD, FAAN An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Jennifer A. Langsdorf, MD Dr. Langsdorf has nothing to disclose.
Giorgia Querin, MD No disclosure on file
Lauren Dowell No disclosure on file
Francois Evoy, MD Dr. Evoy has nothing to disclose.
Bella Ertik, MD No disclosure on file
Jonas Saute, MD No disclosure on file
Kirk A. Frey, MD, PhD No disclosure on file
Vikas Kotagal, MD, FAAN Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Erin E. Manning, MD Dr. Manning has or had stock in Doximity. An immediate family member of Dr. Manning has or had stock in Doximity. The institution of Dr. Manning has received research support from RA Pharma. The institution of Dr. Manning has received research support from Muscular Dystrophy Association.
Aarti Sarwal, MD, FAAN Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Ellen Carl, MS No disclosure on file
Teena Shetty, MD, FAAN Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Scott Kolodny, MD No disclosure on file
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
April L. McVey, MD No disclosure on file
Alberto R. Martinez, MD No disclosure on file
Sean Rogers, MD, PhD No disclosure on file
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Ersin Tan, MD Dr. Tan has nothing to disclose.
Slawomir Michalak, PhD No disclosure on file
Maria E. Gonzalez Toledo, MD No disclosure on file
Gil I. Wolfe, MD, FAAN Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Kushak Suchdev, MD Dr. Suchdev has nothing to disclose.
Robert L. Glover, MD Dr. Glover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. Dr. Glover has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Livanova. Dr. Glover has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis.
Richard H. Swartz, BSc MD PhD FRCPC The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute.
Gregory Norris, MD No disclosure on file
Akio Ikeda, MD Dr. Ikeda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan. Dr. Ikeda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo pharms. The institution of Dr. Ikeda has received research support from sumitomo pharma. The institution of Dr. Ikeda has received research support from UCB Japan. The institution of Dr. Ikeda has received research support from Nihon Kohden. The institution of Dr. Ikeda has received research support from Eli Lilly. The institution of Dr. Ikeda has received research support from Richo.
Joseph V. Campellone, MD, FAAN Dr. Campellone has received personal compensation in the range of $5,000-$9,999 for serving as a Content reviewer with VeriMed.
Monica B. Dhakar, MBBS Dr. Dhakar has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Dhakar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Dhakar has or had stock in Xenon Pharmaceuticals Inc. The institution of an immediate family member of Dr. Dhakar has received research support from NIH. The institution of an immediate family member of Dr. Dhakar has received research support from Medtronics.
Carol Moore No disclosure on file
Sheila Gujrathi No disclosure on file
Amilton A. Barreira, MD No disclosure on file
Edward Fox, MD, PhD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Alicja Kalinowska-Lyszczarz, MD No disclosure on file
Indranil Sen-Gupta, MD Dr. Sen-Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Advisors.
James Potts No disclosure on file
Maysaa M. Basha, MD, FAAN Dr. Basha has nothing to disclose.
Jeffrey Hartung, PhD No disclosure on file
Kyung-Wha Kim, MD No disclosure on file
Adil Maarouf Adil Maarouf has nothing to disclose.
Basar Bilgic, MD No disclosure on file
Maria Cristina San Jose, MD No disclosure on file
Matthew W. Cravets No disclosure on file
Sopio Mataradze No disclosure on file
Pamela Z. New, MD, FAAN No disclosure on file
Adam Andrzey Niezgoda No disclosure on file
Bailey Xiao No disclosure on file
Baris Topcular, MD No disclosure on file
Tuncay Gunduz, MD The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Karl O. Boyle, MD No disclosure on file
Glenn A. Phillips, PhD Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx.
Jeffrey L. Gross, MD No disclosure on file
Taylor A. Finseth, MD No disclosure on file
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Kenneth H. Fischbeck, MD, FAAN Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Manoj Mittal, MD Dr. Mittal has nothing to disclose.
Bichun Ouyang Bichum Ouyang has nothing to disclose.
Jie Li No disclosure on file
Maurizio Zibetti No disclosure on file
Artemio A. Roxas, Jr., MD Dr. Roxas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Philippines.
Karameh Hawash Kuemmerle, MD No disclosure on file
Lorena Jure, MD No disclosure on file
Arun Swaminathan, MD Dr. Swaminathan has nothing to disclose.
Marcela Uribe Roca The institution of Marcela Uribe Roca has received research support from Roche.
Galen Joe No disclosure on file
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Carlo Rinaldi, MD, PhD No disclosure on file
Erik V. Burton, MD Dr. Burton has nothing to disclose.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Nicolas Vitello No disclosure on file
Mary Vo, MD Dr. Vo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vo has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Phillips and Paolicchi.
Shifang Liu No disclosure on file
Melanie Glenn, MD No disclosure on file
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Monica Mann, PhD No disclosure on file
Leslie A. Meltzer, PhD No disclosure on file
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Robert R. Wolff, MD No disclosure on file
Victor Otcheretko No disclosure on file
Duaa Jabari, MD Dr. Jabari has nothing to disclose.
James L. Eubanks, PhD Dr. Eubanks has received personal compensation for serving as an employee of Octave. Dr. Eubanks has stock in TG Therapeutics. Dr. Eubanks has stock in Medtronic.
Thomas A. Buckley, PhD The institution of Dr. Buckley has received research support from Highmark Bluecross Blue Prints. The institution of Dr. Buckley has received research support from NIH/NINDS. The institution of Dr. Buckley has received research support from StateSpace, Inc.
Peter Balicza No disclosure on file
Ligia V. Onofrei, MD Dr. Onofrei has nothing to disclose.
Murat Aksu, MD No disclosure on file
Francesca Baldinetti, MD No disclosure on file
David Kreitzman, MD Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kreitzman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cereval. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Kreitzman has received research support from pharma 2b. Dr. Kreitzman has received research support from Neurocrine. Dr. Kreitzman has received research support from Addex. Dr. Kreitzman has received research support from Amneal.
Lori A. Shutter, MD, FCCM, FNCS, FAAN, FAAN The institution of Dr. Shutter has received research support from NIH. Dr. Shutter has received publishing royalties from a publication relating to health care.
Nina J. Solenski, MD Dr. Solenski has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Multiple. The institution of Dr. Solenski has received research support from HRSA . Dr. Solenski has received intellectual property interests from a discovery or technology relating to health care.
Joshua J. Weaver, MD, FAAN Dr. Weaver has nothing to disclose.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Franck Durif, MD, PhD No disclosure on file
Douglas R. Jeffery, MD, PhD No disclosure on file
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
David M. Greer, MD, FAAN Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Bengt Winblad No disclosure on file
Rebecca M. Pruss, PhD No disclosure on file
Kevin Guskiewicz, PhD, ATC No disclosure on file
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
David Chiu, MD Dr. Chiu has nothing to disclose.
Brian J. Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Thibault Moreau Thibault Moreau has nothing to disclose.
Andrew Chan No disclosure on file
Bernard M. Uitdehaag, MD, PhD, FAAN Dr. Uitdehaag has nothing to disclose.
Hideki Garren, MD, PhD Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.
Olajide A. Williams, MD Dr. Williams has nothing to disclose.
John O. King, MD, FRACP, FAAN Dr. King has nothing to disclose.
Federica Provini No disclosure on file
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
Giovanna Calandra-Buonaura No disclosure on file
Mariko Kita, MD No disclosure on file
Marshall S. Balish, MD, PhD No disclosure on file
Betsy N. Williams, PhD Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Juanzhi Fang No disclosure on file
Serge G. Timsit No disclosure on file
Ross Zafonte, DO Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MYOMO. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kisbee. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. The institution of Dr. Zafonte has received research support from NIDILRR. The institution of Dr. Zafonte has received research support from NIH. The institution of Dr. Zafonte has received research support from FPHS study. Dr. Zafonte has received publishing royalties from a publication relating to health care.
Brian Ahuja, MD No disclosure on file
Venkatesh Aiyagari, MD Dr. Aiyagari has received publishing royalties from a publication relating to health care.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Daniel D. Mikol, MD, PhD Dr. Mikol has received personal compensation for serving as an employee of NervGen. Dr. Mikol has received personal compensation for serving as an employee of Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for NervGen. Dr. Mikol has stock in NervGen. Dr. Mikol has stock in Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NervGen.
Jonathan M. Goldstein, MD No disclosure on file
Davide Pareyson, MD No disclosure on file
Atchayaram Nalini, MBBS No disclosure on file
Arthur R. Dick, MD No disclosure on file
David Baker No disclosure on file
Jun Li, MD, PhD, FAAN The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Kiren Kresa-Reahl, MD Dr. Kresa-Reahl has received personal compensation for serving as an employee of Atara Biotherapeutics Inc.. Dr. Kresa-Reahl has received stock or an ownership interest from Atara Biotherapeutics Inc.
Efrain D. Salgado, MD Dr. Salgado has nothing to disclose.
Nicola De Stefano, MD Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Joan M. Ohayon Joan M. Ohayon has nothing to disclose.
Fulton Velez No disclosure on file
Matthew J. Davis, MD No disclosure on file
Carolyn Mehaffey, MD No disclosure on file
Brian Stephens, MD No disclosure on file
Archana Hinduja, MD Dr. Hinduja has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Meriem K. Bensalem Owen, MD Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a Principle Investigator (PI) with Xenon. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with UCB. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with NeuroPace.
Amelia K. Boehme, PhD Dr. Boehme has nothing to disclose.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Daniel O. Claassen, MD, FAAN Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Letizia M. Leocani, MD Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Florencia Aguirre No disclosure on file
Laura Herbelin No disclosure on file
Fazeel M. Siddiqui, MD No disclosure on file
Samuel F. Hunter, MD, PhD The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Rejean M. Guerriero, MD Dr. Guerriero has nothing to disclose.
Emily A. Johnson No disclosure on file
Emily Brereton Emily Brereton has nothing to disclose.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. The institution of Dr. Robertson has received research support from UCB Biosciences. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Jonathan D. Snider, MD, FAAN Dr. Snider has nothing to disclose.
Jules Osias, MD No disclosure on file
Gina Remington No disclosure on file
Mercè Boada Rovira, MD, PhD Dr. Boada Rovira has received personal compensation for serving as an employee of FUNDACIO ACE. ICNA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LILLY. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NORDISK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOIBERICA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SCHWABE PHARMA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NUTRICIA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERVIER. Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ZAMBON.
Nita A. Limdi No disclosure on file
Nicolas A. Bianchi, MD Dr. Bianchi has received personal compensation in the range of $0-$499 for serving as a Consultant for Innovation Hub Enterprises, LLC. The institution of Dr. Bianchi has received research support from Emory Medical Care Foundation.
Huned S. Patwa, MD, FAAN No disclosure on file
Alessandro Cicolin, MD No disclosure on file
Kimberly Umans No disclosure on file
Ingrid F. De Vasconcellos, MD No disclosure on file
Choon H. Cha, MD, FAAN No disclosure on file
Julia Pakpoor, MBBS No disclosure on file
Crystal Watson Ms. Watson has received personal compensation for serving as an employee of Atara Biotherapeutics. Ms. Watson has received stock or an ownership interest from Atara Biotherapeutics.
Deborah Dukovic No disclosure on file
Hannah Homafar, MD No disclosure on file
Zakraus K. Mahdavi, MD No disclosure on file
Rani A. Sarkis, MD, MSc The institution of Dr. Sarkis has received research support from NINDS.
Christophe Hotermans, MD, PhD No disclosure on file
Eran P. Klein, MD, PhD The institution of Dr. Klein has received research support from NIH.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Dusan Stefoski, MD, FAAN No disclosure on file
Kamal Ahmad No disclosure on file
Alexandra C. Boske, MD Dr. Boske has nothing to disclose.
David Skoloudik, MD, PhD No disclosure on file
Fahd Amjad, MD Dr. Amjad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TEVA. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Amjad has received personal compensation in the range of $0-$499 for serving as a Consultant for abbvie. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyowna Kirin. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for This information is included in the consultant disclosure. The institution of Dr. Amjad has received research support from Roche.
Marcelo C. Kremenchutzky, MD, FAAN No disclosure on file
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Yasar A. Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Maria Malmenäs, MSc No disclosure on file
Catherine A. Madison, MD No disclosure on file
Laurie McWilliams-Dunnigan, MD No disclosure on file
Paul Wicks, PhD No disclosure on file
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Stephen Krieger, MD, FAAN Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Lilyana M. Amezcua, MD, FAAN Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS. The institution of Dr. Amezcua has received research support from Sanofi/Genzyme. The institution of Dr. Amezcua has received research support from Alexion.
Anna D. Hohler, MD, FAAN Dr. Hohler has nothing to disclose.
Valerie Wolff No disclosure on file
Mathias Maurer, MD No disclosure on file
Srilatha Thadur, MD No disclosure on file
Jim Wu No disclosure on file
Francis X. Conidi, DO, MS, FAHS FAAN, FAAN No disclosure on file
Alberto L. Dubrovsky, MD No disclosure on file
Nyaz Didehbani, PhD Dr. Didehbani has nothing to disclose.
Munro Cullum, PhD The institution of Dr. Cullum has received research support from NIH. Dr. Cullum has received intellectual property interests from a discovery or technology relating to health care. Dr. Cullum has received personal compensation in the range of $10,000-$49,999 for serving as a Scientific Director with Texas Alzheimers Research and Care Consortium.
Lusine B. Kirakosyan, MD No disclosure on file
Gregory W. Albers, MD No disclosure on file
Richard R. Murphy, MBChB, FAAN Dr. Murphy has nothing to disclose.
Steven J. Cavalier, MD, FAAN No disclosure on file
Anna M. Fermin, MD No disclosure on file
Christine Kang No disclosure on file
Pavla Cermakova No disclosure on file
Christopher Earley, MD, PhD No disclosure on file
Richard A. Macdonell, MD, FAAN Dr. Macdonell has nothing to disclose.
Gordon S. Francis, MD, FAAN No disclosure on file
Jeremy S. Chataway, MD Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
DaiWai Olson The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Chiesi.
Michael D. Privitera, MD, FAAN Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK life science. Dr. Privitera has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK life science. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Privitera has received research support from Neurelis. The institution of Dr. Privitera has received research support from Biohaven. Dr. Privitera has received research support from Neurava.
Ramesh Madhavan, MD, FAAN Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Maureen Lage No disclosure on file
Amza Ali, MD, FRCP, FAAN No disclosure on file
Andres M. Villa, MD Dr. Villa has nothing to disclose.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Tsao-Wei Liang, MD The institution of Dr. Liang has received research support from Bial R&D Investments S.A.. The institution of Dr. Liang has received research support from Parkinson's Foundation. The institution of Dr. Liang has received research support from AbbVie. The institution of Dr. Liang has received research support from Neuroderm. Dr. Liang has received publishing royalties from a publication relating to health care.
Teresa Frohman, PA No disclosure on file
Kimberly D. Johnson, MD No disclosure on file
Laurie A. Schluter, RN, MSN, FNP No disclosure on file
Gianni Soraru No disclosure on file
Shannon McNally No disclosure on file
Benjamin Turner, MD, MBBS No disclosure on file
Ahmad El Kouzi, MD, FAAN Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Brenda Fonseca No disclosure on file
Mary R. Rensel, MD, FAAN Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Ericka P. Greene, MD, FAAN Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abraham & Watkins Texas Law Firm. The institution of Dr. Greene has received research support from National Science Foundaton .
Charles Kassardjian, MD, FAAN Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Marc De Backer, MD, FBCPM, MBA No disclosure on file
Dennys Reyes, MD No disclosure on file
Brendan J. Kelley, MD, FAAN Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Marcus W. Koch, MD, PhD No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Vesna V. Brinar, MD, PhD No disclosure on file
Stephen M. Graham, PhD No disclosure on file
Aneesh B. Singhal, MD, FAAN An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (好色先生) with Biogen.
Justin C. McArthur, MBBS, MPH, FAAN No disclosure on file
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with 好色先生. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Carlo Pozzilli Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Deepti Zutshi, MD, FAAN Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Thandar Aung, MD Dr. Aung has nothing to disclose.
Luca Massacesi The institution of Luca Massacesi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck-Serono. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Luca Massacesi has received research support from Tuscan Region Government. The institution of Luca Massacesi has received research support from Sanofi. The institution of Luca Massacesi has received research support from Roche. Luca Massacesi has received research support from Merck-Serono.
David K. Li, MD Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
Jonathan K. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for OBT Law. Dr. Smith has a non-compensated relationship as a Committee Member, Clinical Neurophysiology CMOC Pilot, with ABPN that is relevant to AAN interests or activities.
Andrew Russman, DO, FAAN Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Nicolas Gaspard, MD, PhD The institution of Prof. Gaspard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioserenity. The institution of Prof. Gaspard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. The institution of Prof. Gaspard has received research support from Fonds pour la Recherche Scientifique.
Joni M. Clark, MD No disclosure on file
Tawfiq Al-Lahham, MD Dr. Al-Lahham has nothing to disclose.
Jina M. Youn, MD, MS Dr. Youn has nothing to disclose.
Aadi Kalloo No disclosure on file
Serkay Demir No disclosure on file
Cary L. Twyman, MD, FAAN No disclosure on file
Anthony Behin No disclosure on file
Mercedes P. Jacobson, MD The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
Andrei V. Alexandrov, MD The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Molly Zimmerman No disclosure on file
Yasamin Daneshvar, BA No disclosure on file
Kunio Tashiro, MD No disclosure on file
Christopher Bever, Jr., MD, MBA, FAAN No disclosure on file
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Ludo J. Vanopdenbosch, MD, FAAN Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F Hoffmann La Roche. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Valeria Alvarez No disclosure on file
Christopher S. Williams, DO, MPH No disclosure on file
Maria Eriksdotter-Jonhagen No disclosure on file
Jacob George, MD No disclosure on file
Randy Robinson, PhD No disclosure on file
Ana Marques No disclosure on file
Eric R. Siemers, MD Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. Dr. Siemers has or had stock in Acumen Pharmaceuticals.Dr. Siemers has or had stock in Ell Lilly and Company.Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities.
Steven Jacobson Steven Jacobson has nothing to disclose.
Anthony Reder, MD Dr. Reder has nothing to disclose.
Susanne Muehlschlegel, MD, MPH, FAAN Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grace Pharmaceuticals Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Pharmaceuticals Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with 好色先生. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Muehlschlegel has a non-compensated relationship as a Officer of the Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Ernst-Wilhelm Radue, MD Dr. Radue has nothing to disclose.
Serena W. Hung, MD No disclosure on file
Goran Rakocevic, MD, FAAN Dr. Rakocevic has nothing to disclose.
Richard R. Darby, MD Dr. Darby has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for criminal forensic cases. The institution of Dr. Darby has received research support from National Institutes of Health.
Jan M. Faiola No disclosure on file
Diego Silva, MD, PhD No disclosure on file
Qunming Dong No disclosure on file
Giovanna Manzano, MD Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
David Sandness, MD Dr. Sandness has nothing to disclose.
William P. Meehan III No disclosure on file
Steven Perrin, PhD No disclosure on file
Radi S. Shahien, MD Dr. Shahien has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Waimei A. Tai, MD, FAAN Dr. Tai has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gore. Dr. Tai has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple firms.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Mark C. Cascione, MD No disclosure on file
Marc F. Bataillard, MD No disclosure on file
Steven Tobochnik, MD An immediate family member of Dr. Tobochnik has received personal compensation for serving as an employee of Google. Dr. Tobochnik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blackrock Neurotech. Dr. Tobochnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blackrock Neurotech. The institution of Dr. Tobochnik has received research support from US Department of Veterans Affairs.
Cindy McShea No disclosure on file
Catherine Dive-Pouletty No disclosure on file
Andrew G. Engel, MD, FAAN The institution of Dr. Engel has received research support from NIH.
Sarah I. Sheikh, BM Bch, MSc, MRCP, FAAN Dr. Sheikh has received personal compensation for serving as an employee of Takeda.
James D. Berry, MD MPH Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Shigeki Kuzuhara, MD, FAAN No disclosure on file
Melissa Brock Melissa Brock has nothing to disclose.
Antonio Uccelli, MD An immediate family member of Dr. Uccelli has received personal compensation for serving as an employee of Biogen. The institution of Dr. Uccelli has received research support from Merck. The institution of Dr. Uccelli has received research support from Roche.
Erdem Togrol No disclosure on file
Ging-Yuek R. Hsiung, MD, FAAN Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
Claudio G. Mazia, MD No disclosure on file
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Stanley H. Appel, MD, FAAN Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Ryuji Kaji, MD, FAAN Dr. Kaji has nothing to disclose.
Leo H. Wang, MD, PhD, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Gyanendra Kumar, MD, FAAN Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Ruchira M. Jha, MD Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Watcharasarn Rattananan, MD No disclosure on file
Pearce J. Korb, MD, FAAN Dr. Korb has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical 好色先生 Resources.
Neha Safi, MD No disclosure on file
Jose-Rafael P. Zuzuarregui, MD Dr. Zuzuarregui has nothing to disclose.
Lori H. Travis, MD No disclosure on file
Najwa Al-Bustani, MD No disclosure on file
Jason Williams, MD No disclosure on file
Darren M. Stam, PharmD No disclosure on file
Niklas Bergvall No disclosure on file
Harold Koendgen, MD Dr. Koendgen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Koendgen has received stock or an ownership interest from F. Hoffmann-La Roche Ltd .
Tyler J. Story, PhD No disclosure on file
Richard Figler No disclosure on file
Michelle L. Mauermann, MD, FAAN The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
John Hart, MD The institution of Dr. Hart has received research support from Department of Defense.
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Anne S. Lindblad, PhD No disclosure on file
Worthy R. Warnack, Jr., MD No disclosure on file
Martijn Muller, PhD No disclosure on file
Syed F. Ali, MD No disclosure on file
Ali Hassan, MD No disclosure on file
Ahmad R. Abuzinadah, MBBS No disclosure on file
Siddharth Kapoor, MD Dr. Kapoor has nothing to disclose.
Mark A. Callow, MD No disclosure on file
John P. Sullivan, MD No disclosure on file
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Tatjana Novakovic-Agopian, PhD No disclosure on file
Barry A. Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Mark C. Spitz, MD, FAAN No disclosure on file
Jennifer Simpson, MD Dr. Simpson has nothing to disclose.
Margherita Milone, MD, FAAN Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Victoria S. Pelak, MD, FAAN Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-ophthalmology Society. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.
Kathleen Hawker, MD No disclosure on file
Basil Sharrack, MD, PhD, FAAN Dr. Sharrack has nothing to disclose.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Tobias Derfuss, MD No disclosure on file
Alaa Abu Saleh No disclosure on file
Nicte Mejia, MD, MPH, FAAN Dr. Mejia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mejia has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mejia has received research support from Biogen Foundation.
Jacqueline A. Nicholas, MD Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
Mohamed Kazamel, MD Dr. Kazamel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharamceuticals. Dr. Kazamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea Therapeutics.
Deborah Y. Bradshaw, MD, FAAN The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Amy P. Perrin Ross, RN, APN MSN, CNRN Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for Alexion. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Annette Okai, MD, FAAN Dr. Okai has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme . The institution of Dr. Okai has received research support from Sanofi Genzyme. The institution of Dr. Okai has received research support from Roche Genetech. The institution of Dr. Okai has received research support from Novartis. The institution of Dr. Okai has received research support from EMD Serono. The institution of Dr. Okai has received research support from TG Therapeutics.
Kathleen M. McEvoy, MD, PhD No disclosure on file
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Nazem Atassi, MD Dr. Atassi has received personal compensation for serving as an employee of Sanofi. Dr. Atassi has stock in Sanofi.
Adithya Sivaraju, MD Dr. Sivaraju has nothing to disclose.
Shin J. Oh, MD, FAAN No disclosure on file
Juan Politei No disclosure on file
Jeremy Hua No disclosure on file
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Danielle L. Weiss, MD No disclosure on file
Konrad J. Werhahn, MD No disclosure on file
Amy C. Visser, MD No disclosure on file
Ian T. Rossman, MD, PhD No disclosure on file
Lisa E. Farnett, PharmD Ms. Farnett has received personal compensation for serving as an employee of Sanofi. Ms. Farnett has stock in Sanofi.
Gulden Ozen, MD, PhD No disclosure on file
Ken Liu No disclosure on file
Analia Calle Analia Calle has nothing to disclose.
Shamaehah Javed, MD No disclosure on file
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Wondwossen G. Tekle, MD Dr. Tekle has nothing to disclose.
David J. Dickoff, MD No disclosure on file
Vishal Jani, MD Dr. Jani has nothing to disclose.
Jean Philippe Ranjeva No disclosure on file
Ty Alekzander F. Talamera, MD No disclosure on file
Kazuko Matsuda, MD No disclosure on file
Lewis B. Morgenstern, MD, FAAN No disclosure on file
Geoffrey L. Heyer, MD No disclosure on file
Markku Partinen, MD, PhD, FAAN No disclosure on file
Jesus E. Pina-Garza, MD Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
Jeremy C. Hobart, MD Dr. Hobart has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Hobart has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Takuya Matsushita No disclosure on file
Rebekah Mannix, MD, MPH No disclosure on file
Laurent Tatu, MD No disclosure on file
Elie Naddaf, MD Dr. Naddaf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expert Connect. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Klick, Inc. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcellx. The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro. The institution of Dr. Naddaf has received research support from Cabaletta . The institution of Dr. Naddaf has received research support from Arcellx.
Ankur Doshi No disclosure on file
Kristin Halvorsen No disclosure on file
Francisco J. Gomez, MD No disclosure on file
Harn Shiue, PharmD Dr. Shiue has nothing to disclose.
Christian Cornelissen No disclosure on file
John D. Hixson, MD Dr. Hixson has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hixson has received personal compensation for serving as an employee of Nile Ai. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NextSense Inc.. Dr. Hixson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seer Medical. Dr. Hixson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Epilepsy Study Consortium.
Chantale O. Branson, MD, MSCR, FAAN Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Gaelle Klingelschmitt Gaelle Klingelschmitt has received personal compensation for serving as an employee of F.Hoffmann-La Roche LTD.
Ayman A. Al-Salaimeh, MD Dr. Al-Salaimeh has nothing to disclose.
Angela Y. Peters, MD The institution of Dr. Peters has received research support from NIH.
Hakan I. Gurvit, MD No disclosure on file
Lily J. Henson, MD, MMM, FAAN Dr. Henson has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms. An immediate family member of Dr. Henson has received publishing royalties from a publication relating to health care.
Mikolaj Pawlak, MD PhD Dr. Pawlak has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgalign . Dr. Pawlak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inteneural Networks Inc. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RSQ. Dr. Pawlak has received publishing royalties from a publication relating to health care.
Mario F. Dulay, PhD No disclosure on file
Vanessa Marques No disclosure on file
Jerome J. Graber, MD, MPH, FAAN Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with 好色先生 that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Violaine K. Harris, PhD No disclosure on file
Kimbra L. Kenney, MD, FAAN Dr. Kenney has nothing to disclose.
Anastasia Wells, MD No disclosure on file
Sydney Chirls No disclosure on file
Jun-ichi Kira, MD, PhD Dr. Kira has nothing to disclose.
Amro Stino, MD Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. The institution of Dr. Stino has received research support from GBS-CIDP Foundation. The institution of Dr. Stino has received research support from Bristol Myers Squibb.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Gereon Nelles, MD, PhD, FAAN Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Memodio. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industrial. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for German Neurologists Professional Organization. Dr. Nelles has received publishing royalties from a publication relating to health care.
Fen Bao Fen Bao has nothing to disclose.
Erin P. McCormack No disclosure on file
Sean C. Rose, MD, FAAN Dr. Rose has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Summit Experts. The institution of Dr. Rose has received research support from Dale Earnhardt Jr Foundation.
Sigbert Jahn, MD, PhD No disclosure on file
Michelle C. Johansen, MD Dr. Johansen has received research support from NINDS/NIA. Dr. Johansen has received research support from American Heart Association.
Murat Kurtuncu, MD Dr. Kurtuncu has nothing to disclose.
Davit Eliauri, MD No disclosure on file
Selda Korkmaz, MD No disclosure on file
Yury N. Bykov, MD, FAAN Dr. Bykov has nothing to disclose.
Michael Clark No disclosure on file
Michael K. Hehir II, MD Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- 好色先生. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Bjorn E. Oskarsson, MD, FAAN Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AnnJi. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tsumura. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MediciNova. The institution of Dr. Oskarsson has received research support from Biogen. The institution of Dr. Oskarsson has received research support from Medicinova. The institution of Dr. Oskarsson has received research support from Cytokinetics. The institution of Dr. Oskarsson has received research support from Calico. The institution of Dr. Oskarsson has received research support from Mitsubishi. The institution of Dr. Oskarsson has received research support from Tsumura. The institution of Dr. Oskarsson has received research support from Sanofi. The institution of Dr. Oskarsson has received research support from AZTherapeutics. The institution of Dr. Oskarsson has received research support from Orion. The institution of Dr. Oskarsson has received research support from Esaii.
Peter S. Chin, MD No disclosure on file
Syed Omar Shah, MD Dr. Shah has nothing to disclose.
Angelia Kirkpatrick Angelia Kirkpatrick has nothing to disclose.
Luay Shayya, MD No disclosure on file
Daniel L. Labovitz, MD An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Diana Richardson, MD No disclosure on file
Nassim Naderi, MD No disclosure on file
Carla E. Santiago-Martinez Ms. Santiago-Martinez has nothing to disclose.
Helen Barkan, MD, PhD No disclosure on file
Laurent D. Kremer Laurent D. Kremer has nothing to disclose.
Elizabeth D. McNeil No disclosure on file
Sevim Erdem-Ozdamar, MD No disclosure on file
Audrey Rico Lamy No disclosure on file
Tami Rachmilewitz No disclosure on file
Ani Mnatsakanian No disclosure on file
Erika Silverman Ms. Silverman has nothing to disclose.
Ayesha Sherzai, MD No disclosure on file
James Im, MD Dr. Im has nothing to disclose.
Jon Yankey No disclosure on file
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Nimish Thakore, MD No disclosure on file
Edward M. Kaye, MD No disclosure on file
Eli Silber, MD Dr. Silber has nothing to disclose.
Rashida A. Williams No disclosure on file
Gwendoline Shang No disclosure on file
John D. Lloyd, PhD No disclosure on file
Blair Leavitt, MD Dr. Leavitt has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Incisive Genetics. Dr. Leavitt has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Leavitt has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design TX. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReMix Tx. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Triplet Tx. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Leavitt has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Incisive Genetics. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Huntington's Disease. Dr. Leavitt has stock in Incisive Genetics. Dr. Leavitt has stock in SRNAlytics. The institution of Dr. Leavitt has received research support from CIHR. The institution of Dr. Leavitt has received research support from HSC. The institution of Dr. Leavitt has received research support from Brain Canada. The institution of Dr. Leavitt has received research support from NMIN. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Takashi Imai No disclosure on file
Doulia Hamad No disclosure on file
Emily J. Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Ping-Ru T. Ko, MD No disclosure on file
Brannon L. Vines, MD Dr. Vines has nothing to disclose.
Ernesto Augusto Fulgenzi, MD No disclosure on file
Premkumar Nattanmai Chandrasekaran, MD Dr. Nattanmai Chandrasekaran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma.
Jack J. Lin, MD Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea.
Karen M. Weidenheim, MD No disclosure on file
Allan Olson, MD No disclosure on file
Wilfried Hauke No disclosure on file
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Eric Klawiter, MD, FAAN Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Martin Rakusa, MD No disclosure on file
Michael McDermott No disclosure on file
Agustina Tamargo No disclosure on file
Grant Iverson, PhD Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sway Medical. Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NanoDX. The institution of Grant Iverson, PhD has received research support from Wounded Warrior Project. Grant Iverson, PhD has received publishing royalties from a publication relating to health care. Grant Iverson, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with NeuroHealth, LLC.
Ryo Yamasaki No disclosure on file
Tinatin Kherkheulidze No disclosure on file
Brian J. Piper, PhD No disclosure on file
Jennifer Petrillo Billet, PhD Jennifer Petrillo, 14951 has received personal compensation for serving as an employee of Sage Therapeutics. Jennifer Petrillo, 14951 has received stock or an ownership interest from Sage Therapeutics.
Dan Neftalie A. Juangco, MD Dr. Juangco has nothing to disclose.
Lesli E. Skolarus, MD, MS The institution of Dr. Skolarus has received research support from NIH.
J Renfroe, MD Dr. Renfroe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage Therapeutics. Dr. Renfroe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Renfroe has received intellectual property interests from a discovery or technology relating to health care.
Adham Jammoul, MD No disclosure on file
Ali Alsanousi, MD, MBBS, PhD, Msc I No disclosure on file
Miriam E. Koch No disclosure on file
Paul Shin No disclosure on file
Stuart Yablon, MD No disclosure on file
Alzira A. Carvalho, MD No disclosure on file
Matthew R. Lincoln, MD, DPhil FRCPC No disclosure on file
Joseph Frank No disclosure on file
Giles Campion, MD, PhD No disclosure on file
Kumar Rajamani, MD, FAAN Dr. Rajamani has nothing to disclose.
Sarah J. Banks, PhD No disclosure on file
Richard L. Levy, MD, FAAN No disclosure on file
Rupert Sandbrink, MD, PhD Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Marc Verin Mr. Verin has nothing to disclose.
Karen Sundell Karen Sundell has received personal compensation for serving as an employee of Acumen Pharmaceuticals . Karen Sundell has stock in Acumen Pharmaceuticals .
Lieven G. Lagae, PhD Dr. Lagae has nothing to disclose.
Adam Ziemann, MD, PhD Dr. Ziemann has received personal compensation for serving as an employee of AbbVie. Dr. Ziemann has received stock or an ownership interest from AbbVie.
Dronacharya Lamichhane, MD No disclosure on file
Dasha Kenlan No disclosure on file
Maria S. Pacha No disclosure on file
Rachel Salazar, PT No disclosure on file
Jacek Losy, MD, PhD No disclosure on file
Aline P. Oliveira No disclosure on file
Raquel C. Pereira No disclosure on file
Gunes Esendagli Gunes Esendagli has nothing to disclose.
Benjamin H. Fuchs, MD Dr. Fuchs has nothing to disclose.
Richard S. Nicholas, FRCP Dr. Nicholas has nothing to disclose.
Pierre R. Bourque, MD Dr. Bourque has nothing to disclose.
Annette Sauter, PhD Dr. Sauter has received personal compensation for serving as an employee of F.Hoffmann-La Roche .
Leslie Guthery Leslie Guthery has nothing to disclose.
Rashmi Rao, MD Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Theranica. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Headache Society.
Stacey L. Hughes No disclosure on file
William Sugrue, MD No disclosure on file
Thomas Leist, MD, PhD, FAAN Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Janis Daly, MS PhD No disclosure on file
Rodney D. Bell, MD Dr. Bell has received publishing royalties from a publication relating to health care.
Aaron M. Anderson, MD Dr. Anderson has nothing to disclose.
Dieter Haering Dieter Haering has received personal compensation for serving as an employee of Novartis.
Pamela Delgado No disclosure on file
L. C. Turtzo, MD, PhD No disclosure on file
Sven Schippling No disclosure on file
Deborah A. Lee, MD, PhD No disclosure on file
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Raymond Hupperts No disclosure on file
Artem Kaplan, MD, PhD No disclosure on file
Varun Shandal, MD Dr. Shandal has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for The Killino Firm, P.C..
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Kristina I. Johnson No disclosure on file
David F. Long, MD No disclosure on file
Duarte G. Machado, MD, FAAN Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Andrew Lee, MD No disclosure on file
Lynn Kataria, MD Dr. Kataria has nothing to disclose.
Darryl C. De Vivo, MD, FAAN Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Robert A. Dean Robert A. Dean has received personal compensation for serving as an employee of Acumen Pharmaceutics. Robert A. Dean has received personal compensation for serving as an employee of Gates Ventures. Robert A. Dean has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Robert A Dean Consulting, LLC. Robert A. Dean has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Pietro Guaraldi, MD, PhD No disclosure on file
Yuebing Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
Rod Foroozan No disclosure on file
Karin Mente, MD Dr. Mente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spear Bio. The institution of Dr. Mente has received research support from National Institute on Aging. The institution of Dr. Mente has received research support from Michael J Fox Foundation.
Oscar Martinez, MD No disclosure on file
Jessie Oldham No disclosure on file
Jacob Leary No disclosure on file
Andrew Welleford, MD, PhD Dr. Welleford has nothing to disclose.
Kory Schuh Kory Schuh has received personal compensation for serving as an employee of Eli Lilly and Company.
Jessica L. Hedeman, DO No disclosure on file
Uzma Hussain, MD No disclosure on file
Keith R. Albrektson No disclosure on file
Emmanuel THOMAS No disclosure on file
Bradley Class No disclosure on file
Rajesh K. Goit No disclosure on file
Devon Cohen, MD No disclosure on file
Reyna Duron, MD No disclosure on file
Kiran Polavarapu, MBBS Dr. Polavarapu has nothing to disclose.
Sabrina Paganoni, MD, PhD Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Jennifer DeWolfe, DO No disclosure on file
Katherine Werbaneth No disclosure on file
Victor Lami, MD Dr. Eslami has nothing to disclose.
Michael T. Sawa, MD No disclosure on file
Hasan Askari, MD No disclosure on file
Kottil W. Rammohan, MD Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Antonio Laurenza, MD Dr. Laurenza has received personal compensation for serving as an employee of Takeda. Dr. Laurenza has stock in Takeda.
Jacqueline Urtecho, MD Dr. Urtecho has nothing to disclose.
Natalie P. Valle, MPH No disclosure on file
Charles Yonan, PharmD No disclosure on file
Mona Stecker No disclosure on file
Dana C. Hilt, MD Dr. Hilt has received personal compensation for serving as an employee of Actinogen Medical. Dr. Hilt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brenig Therapeutics.
Fatai M. Akemokwe, MBBS Dr. Akemokwe has stock in CVS HEALTH CORP. Dr. Akemokwe has stock in LABORATORY CORP AMERICAN HOLDINGS.
Karla Alaka No disclosure on file
Nuria Carrillo, MD No disclosure on file
Cristina R. Wohlgehagen, MD No disclosure on file
Alyson Plecash, MD Dr. Plecash has nothing to disclose.
Valeria Lujan Salutto Valeria Lujan Salutto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for alexion astrszeneca.
Mark E. Beatty, MD No disclosure on file
Shyam S. Rao, MD No disclosure on file
MANJUNATH M. POOJAR, MD No disclosure on file
Thor S. Stead Mr. Stead has nothing to disclose.
Elias G. Karroum, MD Dr. Karroum has nothing to disclose.
Piyush Ostwal, MBBS, DM No disclosure on file
Braeden D. Newton No disclosure on file
Preethish Kumar Veeramani, MBBS, PhD, FRCP(Lon) Dr. Veeramani has nothing to disclose.
Fatima Pantiu No disclosure on file
Andrew Gardner No disclosure on file
Pandompatam Govind No disclosure on file
Stuart J. McCarter, MD The institution of Dr. McCarter has received research support from NIH. The institution of Dr. McCarter has received research support from American Academy of Sleep Medicine Foundation.
Christian Von Hehn, MD, PhD Dr. Von Hehn has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Von Hehn has stock in Takeda Pharmaceuticals.
Mat D. Davis Mat D. Davis has received personal compensation for serving as an employee of Teva pharmaceuticals. Mat D. Davis has received stock or an ownership interest from Teva Pharmaceuticals.
Kelli A. Herrlinger No disclosure on file
Scott W. Andersen Scott W. Andersen has received personal compensation for serving as an employee of Eli Lilly. Scott W. Andersen has stock in Eli Lilly. Scott W. Andersen has received personal compensation in the range of $100,000-$499,999 for serving as a Statistician with Eli Lilly.
April Minsky No disclosure on file
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Roger L. Albin, MD Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex. The institution of Dr. Albin has received research support from NIH-NINDS. The institution of Dr. Albin has received research support from Parkinson's Foundation. The institution of Dr. Albin has received research support from Michael J. Fox Foundation. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as a Grant Application Reivewer with Michael J. Fox Foundation.
Kathy L. Ales, MD No disclosure on file
Hidenori Ogata No disclosure on file
Radoslaw Kazmierski, MD, PhD Dr. Kazmierski has nothing to disclose.
Anthony L. Ritaccio, MD, FAAN The institution of Dr. Ritaccio has received research support from NIH. Dr. Ritaccio has received intellectual property interests from a discovery or technology relating to health care.
Roomana Ahad No disclosure on file
Derrick Fox, MD No disclosure on file
Breanna Caruso No disclosure on file
Paul Frohna, MD, PhD, PharmD No disclosure on file
Tanya Bogoslovsky, MD, FAAN Dr. Bogoslovsky has received personal compensation for serving as an employee of Eisai Inc.
Kevin Phan No disclosure on file
Sharmi T. Shafi, MD No disclosure on file
Anthony A. Kubeyinje, Sr., MBBS No disclosure on file
Christina R. Cook, PhD No disclosure on file
Martin Kriebaum No disclosure on file
Amy Wang No disclosure on file
Gilles Edan, MD No disclosure on file
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Ryan Crooks, MD Dr. Crooks has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Chubb.
Nicole D. Mahdi, MD No disclosure on file
Lindsay R. Chura, PhD No disclosure on file
Adam J. Simon, PhD No disclosure on file